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Mechanobiology, a relatively young field that centers on how external physical 
forces on cells or tissues and their intrinsic mechanical properties can influence 
physiology and disease, has become a pillar in cell biology. Indeed, cells experience a 
myriad of external, mechanical stimuli such as shear stress, stretch, substrate and 
matrix rigidity, surface topography, compression, and inter-cellular junction forces. 
Mechanosensors on the cell surface interfacing with the external environment (e.g., 
receptors, mechanosensitive ion channels, focal adhesions) and within the cell (e.g. 
the cytoskeleton) can sense, transmit, and amplify these inputs. This results in a 
cascade of intracellular biochemical signaling that leads to altered gene expression, 
protein expression, and finally, altered cell behavior and function. This process is 
known as mechanotransduction.  
Mechanotransduction at the cellular-scale has perceptible, large-scale 
implications such as proper organism development, our ability to sense sound and 
touch, function and homeostasis of organ systems, and disease progression. Previous 
work in mechanobiology has focused on investigating or capitalizing on native, 
endogenous mechanotransduction. This dissertation work proposes a relatively 
unexplored frontier in mechanobiology: exogenous mechanotransduction, by 
demonstrating a novel approach towards achieving signal transduction and 
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mechanically driven behavior in cells through the introduction of exogenous 
mechanosensory components.  
Here we demonstrate how the functional expression of the E. coli membrane 
tension gated mechanosensitive channel of large conductance (MscL) in mammalian 
cells endows the cells with new mechano-sensing capabilities such as the activation 
of MscL in the plasma membrane through membrane tension resulting from (1) 
osmotic down-shock and (2) new interactions with native mechano-sensory 
components, as well as altered cell function such as (3) impairment of cell migration 
in metastasis in vivo  and narrow, 3D confinement in vitro.  
The first major contribution in this thesis was to show that MscL can be 
expressed in mammalian cells, localize to cellular membranes, and responds to 
membrane tension via osmotic down-shock. The second contribution was 
demonstrating that the activation of the bacterial MS channel expressed in 
mammalian cells can be mediated through localized membrane stress that is 
dependent on the native actin-cytoskeleton. This was done by using acoustic tweezing 
cytometry (ATC) where acoustic excitation of microbubbles targeted to surface 
integrin receptors generated localized forces that robustly gated MscL. Impermeable, 
fluorescent dye uptake was used to report MscL activation; also showing that 
activated MscL can deliver large molecules into the cell. 
Lastly, we investigated the effect of MscL mechanotransduction on the cell 
function of migration in cancer metastasis and then more specifically, 3D-
confinements. Our findings in our in vivo mouse model showed that there was a 
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marked reduction in metastasis to the lung for MscL expressing cancer cells 
compared to controls. In vitro migration experiments using a biomimetic microfluidic 
device revealed that MscL activation due to 3D-confined migration could be 
responsible for the observed reduction in metastasis. We found that ~46% of MscL-
expressing cancer cells that entered extremely narrow confinements of 30 µm2 cross-
section had activated MscL and only 11% of these cells were able to fully enter the 
channel and migrate.  
Implications of this thesis are that MscL: (1) can be used as a molecular delivery 
tool for live-cells via mechanical stimulus; (2) can provide insight into the metastatic 
cascade and mechanobiology focused therapies; and (3) in mammalian cells can serve 
to study existing mechanotransduction or potentially engineer new mechanical 








Background, Motivation, & Research Objectives 
This thesis is in the field of mechanobiology and demonstrates for the first time 
exogenous mechanotransduction in mammalian cells through the novel approach of 
functional expression of an exogenous, bacterial mechanosensor, mechanosensitive 
channel of large conductance, (MscL). In this chapter background and motivation on 
mechanobiology, mechanotransduction, and MscL is provided. To-date 
mechanobiology has primarily focused on endogenous mechanotransduction leading 
to many technological advancements and significant amassed knowledge. This has 
set the stage for moving into the unexplored area of exogenous mechanotransduction 
and engineering mechanotransduction for attractive mechanobiology applications. To 
achieve this goal, bacterial MscL was identified as a suitable mechanosensor. 
 
Mechanobiology and Mechanotransduction 
Mechanobiology, a relatively young field, centered on how physical forces on 
cells or tissues and their intrinsic mechanical properties can influence physiology and 
disease, has already become a pillar in cell biology. Indeed, cells experience a myriad 
of external, mechanical stimuli such as shear stress, strain, substrate and matrix 
rigidity, topography, osmosis, compression, and inter-cellular junction forces (Figure 
 2 
1.1). Mechanosensors on the cell surface that interface with the external 
environment, including receptors, mechanosensitive ion channels, protein complexes 
such as focal adhesions, and within the cell, such as the cytoskeleton, can sense, 
transmit, and amplify these inputs. This results in a cascade of intracellular 
biochemical signaling that ultimately leads to altered gene expression, protein 
expression, and finally, a change in cell behavior and function. This process is known 
as mechanotransduction. 
Mechanotransduction occurring at the cellular-scale has perceptible, large-
scale implications such as our ability to sense sounds and touch, the proper 
functioning of organ systems, interpretation of key external cues for organism 
development, and disease progression. This has motivated researchers in recent 
decades to reach many milestones in mechanobiology (Figure 2). Significant 
discoveries include that of the integrin family proteins[1, 2], mechanosensitive 
channels in bacterial cells via patch clamp experiments [3, 4], control of stem-cell 
differentiation and proliferation into various cell types by tuning substrate stiffness 
[5-7], linking human genetic disorders to defective mechanosensors such as anemia 
xerocytosis resulting from a mutation in mechanosensitive channel Piezo [8], and 
differences in cancer and diseased cell deformability compared to healthy, somatic 
cells allowing for mechanical phenotyping [9, 10]. 
Mechanobiology is at the intersection of biology and engineering, which is 
evident as it focuses on physical forces on biological systems; but this is also evident 
in many of its breakthroughs that consist of discoveries tightly coupled to technologic- 
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Figure 1.1 Diagram Summarizing Mechanobiology of a Single Cell. Left: image legend; and a close-up view of a 
focal adhesion that binds to the ECM via integrins and assembles an intracellular protein complex that connects 
to the cell cytoskeleton. Center: a cell with representative physical stimuli and mechanosensors. Right: 
mechanotransduction cascade (adapted from Sun et al., 2012) [11] 
 
-al advancements and application of state-of-the-art tools [12]. Technological 
advancements, many borrowed from engineering applications, such as variable 
stiffness silicone substrates [5, 13], traction force microscopy [14], optical tweezing 
cytometry and atomic force microscopy [15, 16], super-resolution imaging [17, 18], and 
microfluidic devices [19, 20] have opened previously inaccessible lines of inquiry. 
Though these milestones span various mechanosensors, cell functions, 
signaling pathways, and technologies, all have focused on investigating or 
capitalizing on native, endogenous mechanotransduction. We have reached a point in 
our amassed mechanobiology knowledge where we can begin to engineer novel 
mechanotransduction to further our understanding and open new paths toward 
innovation. In this thesis, we propose moving into this relatively unexplored frontier 
in mechanobiology and show a logical approach to achieving the goal of engineering 
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novel signal transduction and mechanically driven behavior in cells through the 
introduction of exogenous mechano-sensory components.  
We focus on using the E. coli mechanosensitive channel of large conductance 
(MscL) as the exogenous mechanosensor. MscL is a membrane tension activated 
channel protein that has no direct homolog in mammalian cells and thus has many 
unique attractive mechano-sensing features not typical in mammalian cells. This, 
coupled with the fact that MscL is the best studied MS channel to date make MscL 
highly suitable for achieving novel mechanotransduction in mammalian cells. 
 
Mechanosensitive channel of large conductance (MscL) 
Introduction: Mechanosensitive (MS) channels are a class of dynamic, 
mechanically gated molecules and are among the best-characterized force-sensing 
systems. MscL was first identified in 1987 from early electrophysiological studies of 
giant E. coli spheroplasts [4]. This along with other early observations demonstrated 
that these MS channels were activated by pressure, had large conductance, and 
resided on the inner, cytoplasmic membrane of E. coli [3]. It was hypothesized that 
MscL functions as an “emergency release valve”, protecting cells from lysis under 
turgor pressure.  
mscL Gene, Crystal Structure, and Protein Reconstitution: To study MscL in 
depth, the mscL gene encoding for the protein needed to be ascertained. The 
identification and cloning of the mscL gene was a tremendous feat, requiring the use 








































































































protein to gene). To acquire the MscL protein, numerous steps of patch clamp 
functional assaying followed by fractionation then followed by reconstitution into 
liposomes were performed until obtaining an MscL-only fraction [21]. 
This allowed researchers to independently reconstitute MscL into 
proteoliposomes (i.e., purified proteins reconstituted into liposomes); and further 
patch-clamp experiments on these systems determined that MscL functions 
independently from other proteins or molecules and is exclusively gated (or opened) 
by membrane tension [22]. Patch clamp characterization of MscL determined its gating 
threshold tension to be close to 10.4 mN m−1 [23]. 
The MscL protein crystal structure was determined from M. tuberculosis and 
S. aureus [24, 25]. Based on those structures, the E. coli channel is predicted to have a 
pentameric configuration, with five symmetrically arranged subunits about the 
channel pore [26, 27] (Figure 3). The subunits consist of two transmembrane domains 
(TM1 and TM2), N- and C-terminal cytoplasmic domains, and a periplasmic loop. The 
channel has a funnel shape, with the larger opening lined by TM1 and facing the 
periplasmic surface, and the narrowest point facing the cytoplasm, plugged by 
hydrophobic residues Leu19 and Val23 [28, 29]. 
Structure-Function Relationships: After MscL’s discovery, gene isolation, and 
determination of its crystallographic structure, researchers began to probe into MscL 
domains structure-function and the channels gating mechanism. An early study on 
structure-function focused on the contributions of the extra-membranous domains of 
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the channel (i.e., N-terminus, C-terminus, and periplasmic loop) to the channel 
activity and did so by utilizing specific proteolysis. Using an excised patch clamp- 
 
Figure 1.3 MscL Structure. (A) Ribbon model of closed MscL channel protein side view with subunits denoted by 
different colors and some protein domains labeled embedded in a lipid membrane (light orange band) (B) side 
view of MscL channel in the open configuration, membrane is under tension and thinner (C) A single subunit view 
under membrane tension. Key residue-membrane anchors shown with respective applied forces on the N-terminal 
and TM2 domains. (D) Simple diagram of the tilting of the TM1, inner pore domain during channel gating. As the 
N-terminal anchor is pulled, it transmits force along TM1, aligning TM1 into a continuous helix and opening the 
channel pore. (E) List of all MscL subunit domains and respective amino acid residues. (F) Top view of open MscL 
channel showing a maximum pore size of 3 nm. (Adapted from Martinac and Cox, 2016 and Wang et al., 2014 [30, 
31]) 
 
mode on single channels, the researchers claimed they were able to selectively expose 
the cytoplasmic facing side or periplasmic facing side of the channels to protease. For 
the C and N-termini, proteolysis showed an increase in the mechanosensitivity of the 
channel without changing its conductance [32]. In contrast, after cleavage of the 
periplasmic loop for each monomer, the channel was still functional with dramatically 
increased mechanosensitivity. The loop does this by acting as a spring that resists 
the opening of the channel and helps MscL’s closure when it is open. It must be noted 
that the effect of proteases trypsin or chymotrypsin was only observed when the 




protease-sensitive sites. Also, to note is that due to the lack of precision of the 
proteolysis, it is not known what the exact deletions were on these domains. For the 
N-terminus it can be assumed that at least the deletion of the first 7-10 amino acids 
(i.e., up to the Phe residues) resulted in increased sensitivity. Together these results 
indicate that the integrity of most of the extra-membranous domains is not necessary 
for mechanosensitivity. They instead suggest that they counteract the changes of the 
transmembrane helices and potentially set the level of sensitivity of the channel to 
tension. 
A more precise explanation of MscL’s N-terminal function was recently 
revealed using finite element (FE) and molecular dynamics (MD) simulations in 
conjunction with spin-labelling and electron paramagnetic resonance (EPR) 
spectroscopy [33]. The N-terminal domain is a 14-amino acid long amphipathic helix 
that aligns with the membrane-cytoplasmic interface. It acts as an anchor and 
stabilizes the MscL’s closed state. When the lipid bilayer is stretched, the N-terminal 
helix is pulled along the direction of the surrounding lipids and consequently 
transmits force from the Gly4 residue to the end of TM1. TM1 then aligns with the 
N-terminal domain and forms a continuous helix (Figure 3d). The addition of amino 
acid residues to the N-terminus was found to not affect channel activity, however 
deletions or changes to the N-terminal amino acid sequence results in altered 
pressure sensitivity and gating; additions of flexible glycines at the Gly-4 site led to 
an increase in the pressure required for MscL gating [28, 33]. Deletions led to loss of 
sensitivity channel phenotypes where expression of these constructs could not rescue 
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E. coli from hypo-osmotic shock. The most severe loss of sensitivity was seen with a 
Δ2–7 deletion construct, requiring much more force to gate when probed using patch-
clamp electrophysiology. The N-terminal helix of MscL acts as a critical structural 
element in tension-induced gating, both stabilizing the channel’s closed state and 
coupling the channel to the membrane. The N terminus is an essential driver of 
orienting the TM1 domain and the radial expansion of the channel pore [33, 34].  
Similar FE and MD simulation coupled spectroscopic experiments were done 
for the 36-amino acid long C-terminal [35]. The results confirmed that in the MscL 
closed pore configuration, the subunit C-terminals form a bundle of five, hydrophilic 
α-helices concentric with the channel transmembrane bundle and collinear with its 
axis of symmetry (i.e., axis through the channel pore, from the cytoplasm to the 
periplasm). During channel gating, a top section of the C-terminal domain, A110-
E118, dissociates and the remainder of the C-terminus does not change orientation. 
This implied that the C-terminus serves as a molecular sieve and stabilizer of the 
oligomeric MscL structure. Despite the C-terminus function, deletion of 27 amino 
acids from the C-tail does not alter MscL gating in response to pressure, however, 
deletion up to 33 amino acids causes MscL to not activate [28]. Those C-terminal amino 
acids at these sites, 104-108, consist of a highly-conserved cluster, RKKEE, among 
many different MS channels [36]. This conserved region functions as a proton sensor 
of the external environment by adjusting the channel sensitivity to membrane 
tension in a pH-dependent manner by altering the C-terminus orientation. 
Protonation of the basic and acidic chains of residues within the RKKEE charged 
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cluster by a decrease in pH may prevent the channel from opening and led to 
considerably higher pressure threshold for channels in liposomes [36]. 
Later random and scanning mutagenesis of the mscL gene, showed that when 
a hydrophilic amino acid replaces one of the hydrophobic residues on the upper 
interface between the membrane lipid and the channel’s periplasmic end of the 
transmembrane domains, TM1 or TM2, MscL is unable to open in response to 
membrane tension. Loss-of-function mutants have been isolated in the periplasmic 
loop [37]. This change in the sensitivity was suggested to be due to a change in the 
folding and/or stiffness of the loop since through proteolytic digestion of the loop it 
was shown to increase the mechanosensitivity [32]. In TM1- and TM2-loop mutants 
(V37D, I40T, P69L, and M73K) no channel opening or high threshold activation was 
observed. Residues near the end of TM2 (Phe78, Ile79, Phe83, and Ile87) and TM1 
(Leu36, Ile40, and Ile41) mutated with hydrophilic asparagine also lead to lower 
viability and much higher gating threshold suggesting that these sites receive the 
membrane tension from the surrounding lipid through hydrophobic interaction. 
Despite complementing these mutants with TM1 G22X mutants, which were shown 
to increase channel sensitivity, the function of MscL is severely impaired as shown in 
liposome patch-clamp experiments and in vivo hypoosmotic-shock [37]. Hydrophilic 
substitution of other residues at this lipid-protein interface did not impair MscL's 
mechanosensitivity. Disturbing the hydrophobic interaction between the membrane 
lipid and the channel’s periplasmic funnel rim, impairs the function of MscL [37].  
 11 
Gain of Function Mutants: Other random mutagenesis of the TM1 domain, the 
pore-lining helices, had an opposite effect to MscL mechanosensitivity [29]. Instead, 
gain of function (GOF) MscL mutants (i.e., mutants with greater sensitivity and lower 
gating threshold compared to the WT), were discovered [29]. These mutants in E. coli 
were classified into groups of severity that showed increasing leakage of solutes and 
decreasing cell viability. The most severe mutants were found to be on residues 
Gly22, Val23, Gly26, and Gly30. The open probability of the MscL channel as a 
function of applied pressure as determined through patch clamp experimens showed 
that the GOF mutants retain the shape and slope of the WT probability curve but 
was shifted left towards lower pressures indicating the mutants have lower activation 
pressure threshold but the “spatial” gating parameters were not change. The kinetics 
for GOF mutants also differed from WT, where the severe mutants had flickering 
channel activity and open dwell times less than 1 ms as contrasted by WT, which can 
have major open dwell times tens of milliseconds. This result indicated that GOF 
mutants have a lower transition barrier between open and closed states [29].  
Among those previously probed residues, Gly22 is highly conserved in other 
bacterial MscL homologues. In the previous known MscL structure from 
Mycobacterium tuberculosis [24], Gly22 was buried within the constriction within the 
closed channel pore. In order to elucidate the molecular mechanism of the channel 
gating, one study substituted Gly22 with all other common amino acids [38]. 
Substituting of Gly22 with hydrophilic residues decreased the threshold pressure at 
which channels opened. The channel open probability distribution as a function of 
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pressure for the MscL channels were compared to that of the mechanosensitive 
channel of small conductance (MscS). MscS is also expressed in E. coli and is known 
to function similarly to MscL except for having a lower activation threshold, smaller 
conductance, and thus typically activating before MscL in response to membrane 
tension [39-41]. Due to variation in micropipette dimensions in patch experiments, 
MscS was used as an internal control. MscL activation threshold was 1.64x greater 
than that of MscS [42]. The MscL severe GOF mutations listed starting with the most 
severe as N-Asn (e.g., can be activated with no applied pressure), E-Glu, D-Asp, R-
Arg, K-Lys, Q-Gln (e.g., threshold of 0.4x that of MscS), and H-His caused a 
significant decrease in bacterial growth rate and pressure gating threshold. More 
moderate GOF mutants were S-Ser (1.14x MscS threshold) and T-Thr. Channel 
kinetics also varied with hydrophilicity. G22S and G22T exhibited flickering with 
dwell events close to 2 ms. The severe GOF mutants exhibited flickering activity at 
open dwell times closer to 0.5 ms in addition to a stable substrate near or at the lowest 
sub-conductance level of MscL WT of 0.5 nS. MscL has been shown to have multiple 
sub-conducting states between the fully-closed and fully-open states [42]. These 
mutants had two activation thresholds and activation probability for lower applied 
pressure range, which led to transitions from the closed state to the more favored 
sub-conducting state, and higher applied pressure range, which led to transitions 
from the sub-conducting state to a more favored fully-open state [38]. 
Indeed, the TM1 has been shown to be the channel gating hotspot and 
alterations to these amino acids confer the MscL channel chemical gating. GOF 
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mutants such as G22S have been show to require half of the tension needed for 
activation at ~5-6 mN/m while other mutants such as G26C have the added 
advantage of being chemically gated using small reducing agents such as 2-
(trimethylammonium) ethylmethanethiosulfonate bromide (MTSET) [43, 44]. Cysteine 
scanning of the channel, has revealed residues G26, G30, and S34 on TM1, forming a 
vestibule in pore of the channel closed structure, to produce a phenotypic change 
when exposed to MTSET alone. In particular, G26C mutated channel upon 
periplasmic exposure of 2 mM MTSET spontaneously activated, initially sporadically 
residing at multiple sub-states and over a matter of a few seconds becoming “locked” 
into an open sub-state ∼4/5th the fully-open state.  
MscL Gating Mechanism and Conducting States: Understanding the locations 
and gating effects of MscL’s residues have helped researchers produce a clearer 
mechanism of the channel gating, pore dimension, and lipid interactions. MscL is 
gated by tension transmitted through the lipid bilayer. Using purified MscL 
reconstituted in liposomes, researchers have been able to study single channel 
currents as an applied pressure (p) is varied and thus the lipid membrane surface 
tension (T) altered [42]. Video microscopy during patch experiments allowed for the 
calculation of tension by knowing p and the radius of curvature of the liposome in the 
patch pipette. MscL channel activity is often described in terms of its open probability 
(Po), which has a has a steep sigmoidal dependence on T, with a midpoint (T1/2) of 11.8 
dyn/cm (or 11.8 mN/m) [42]. MscL WT has shown a maximal slope sensitivity of Po/Pc 
(where Pc is the closed probability) as 0.63 dyn/cm per e-fold (i.e., time interval in 
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which an exponentially growing quantity increases by a factor of e). It terms of 
energy, the channel state probabilities follow a Boltzmann distribution and the 
energy difference between the closed and fully open states is ΔE = 18.6kBT. Equating 
this free energy to spatial parameters, TΔA, where (ΔA) is the change in the in-plane 
area, gives ΔA = 6.5 nm2.  
MscL is not a binary channel, but has an additional four states. These are 
achieved sequentially as C↔CE↔S1↔S3↔O, where C, CE, S, and O refer to the 
closed, closed expanded, sub-conductance, and open states, respectively [26, 27, 42]. The 
transition from the closed to closed expanded conformation produces no conductance 
and is elastic. When the expansion of the channel rim places sufficient stress the 
channel first opens to a sub-conducting state, S1. The tension dependency of 
transition from the CE to S1 suggested that there is an in-plane area increase, ΔA, of 
∼4 nm2, 2/3rds of the closed to open state ΔA. Low sub-conducting (S1) and fully-open 
(O) state transitions are relatively independent of tension [26]. In order to explain the 
closed expanded state, a model was developed in which the N-termini of the channel 
act as a second gate [26, 42]. This model has since been proven incorrect and the N-
terminal helices have been shown to act as a dynamic membrane coupling element 
that associates with the bilayer at the cytoplasmic interface and drives the tilting of 
the pore-lining TM1 helix [33, 34]. 
The importance of the interactions of MscL and the membrane is supported by 
the observation that variations in the phospholipid bilayer thickness or the addition 
of compounds that induce membrane curvature such as lysophosphatidylcholine 
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(LPC) directly impact the tension required to gate MscL [45, 46]. Thus, membrane 
deformation and tension can be perceived by MscL as a hydrophobic-mismatch at the 
protein-lipid interface, where the opening of the channel results in a favorable 
reduction in free energy. The details of the protein conformational change were 
worked out by Wang et al. by using single molecule FRET (smFRET) of MscL in 
reconstituted liposomes [31]. They were able to (1) demonstrate that the 
conformational change of MscL during gating follows a helix-tilt mechanism, (2) 
report measurements of the distance changes on MscL transmembrane α-helices and 
(3) directly observe that the open pore reaches 2.8 nm in diameter. In addition, based 
on the measurements, they developed a molecular dynamics model of the channel 
structure in the open state which confirmed their experimental findings. 
Unique Advantages and Limitations: These MS channels are predicted to exist 
in all three kingdoms of life [47]. However, in animals, homologs have not been 
identified [48-50]. Unlike identified animal ion channels such as MEC-4/MEC-10, TRP 
or Piezo, MscL presents three novel features (1) cytoskeletal /ECM independent 
function, (2) nonselectivity (i.e., the channel is not ion specific and any molecule 
within the pore diameter limit can traverse the channel), and (3) large pore size [51-
53]. Because of its role as an emergency release valve, bacterial null MS channel 
mutants indeed show markedly less viability under osmotic downshock [54]. When a 
bacterium is in a hypo-osmotic environment, osmosis across the cell’s wall and 
membrane causes the bacterium to swell and stretches the membrane. As a response 
to the swelling, MscS and if needed, MscL, are activated allowing the cell to jettison 
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osmolytes (e.g., ions and small proteins) and rapidly equilibrate the inner and 
external cell osmolarity. Thus, MscL is meant to be triggered as a “last resort” and 
requires high energy to gate it. One of the major foreseeable limitations with the 
application of MscL is its high tension threshold of ~10 mN m-1. As shown by previous 
patch-clamp experiments, the activation of MscL can require pressures close to the 
lytic tension of an unmodified bilayer [55, 56]. However, as discussed previously, single 
point mutations on the TM1 domain or addition of LPC lipid can greatly enhance 
MscL’s mechanosensitivity. 
Previous Work Involving MscL in Mammalian Cells: The application of MscL 
in mammalian cells was recently shown by Doerner et al [57]. In their work, they 
demonstrated functional expression of MscL WT and MscL G26C in CHO and HEK 
293 cell lines using a lentiviral method. Despite performing patch clamp experiments 
with pressure driven gating of both MscL proteins in these mammalian cells, other 
mechanically driven gating was not demonstrated in the work. Instead, MscL gating 
and robust delivery of biomolecules ≤ 10,000 Da into live cells were shown through 
the treatment of the G26C mutant with 1mM MTSET reducing agent. Once 
membrane impermeable dyes such as phalloidin and AF-dextran were able to be 
delivered into live cells with reversible activation of the MscL G26C mutant. They 
found that continuous activation of MscL G26C for up to 8 minutes or more was 
cytotoxic. The addition of MscL and its chemically induced activation conferred the 
new and desirable property of efficient and non-cytotoxic delivery of small to large 
biomolecules into living cells.  
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However, a more detailed study on how MscL integrates into mammalian cells 
and its potential for conferring new mechanotransduction were not explored. In the 
following chapters of this thesis we detail research objectives aimed at utilizing MscL 




We define mechanotransduction as a process consisting of cellular mechano-
sensing, biochemical signaling, and changed cell function/behavior. To achieve novel 
mechanotransduction would then require generating new mechano-sensing, 
signaling, and/or mechanically driven function/behavior in cells. In the following 
three chapters, we will demonstrate how the functional expression of the E. coli MscL 
in mammalian cells endows the cells with new mechano-sensing capabilities such as 
the activation of MscL in the plasma membrane through membrane tension resulting 
from (1) osmotic down-shock and (2) new interactions with native mechano-sensory 
components, as well as altered cell function such as (3) impairment of cell migration 
in metastasis in vivo and narrow, 3D confinement in vitro.  
Objective 1 - Activation of MscL as a Response to Osmotic Down-shock: As 
mentioned in Chapter I, previous work on MscL in mammalian cells did not explore 
MscL localization and mechano-sensing in detail[57]. We show that MscL localizes to 
multiple cellular membranes, including the plasma membrane. To then test MscL 
WT and G22S mutant mechano-sensing, we utilize osmotic down-shock. Based on 
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MscL’s function as an emergency release valve in bacteria, we hypothesized that 
MscL could be activated in mammalian cells via membrane tension induced by 
osmotic down-shock. Working with larger mammalian cells, compared to bacteria, 
allowed for the use of fluorescent dye uptake as a reporter of MscL gating/activation. 
This mode of MscL activation was simple enough to be used as a functional assay in 
mammalian cells. Detailed experimental procedures and findings are provided in 
Chapter II. 
Objective 2 - Activation of MscL via New Interactions with Native 
Mechanosensory Components: After showing expression and mechanical activation 
of MscL in mammalian cells we set out to investigate MscL gating as result of 
different types of mechanical perturbation, as shown in Chapter III. We were able to 
show robust activation of MscL via external force applied to surface integrins linked 
to intact actin cytoskeletons. These results showed a new interaction of MscL with 
native, mammalian mechano-sensory components. It is likely that direct 
perturbation of these mechano-sensors on the plasma membrane resulted in 
sufficient, localized membrane stress to activate adjacent MscL. 
Objective 3 - Altered Cell Function: Migration: Lastly, in Chapter IV we 
investigated the effect of MscL mechanotransduction on the cell function of migration 
in cancer metastasis and then more specifically, 3D-confinements. During the 
physiological process of metastasis, cancer cells migrate through narrow pores and 
channels undergoing significant deformation[58, 59]; and in these 3D confined spaces 
cancer cells have been shown to utilize motility mechanism that rely on the actin-
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cytoskeleton and myosin[60], or native aquaporins and ion channels[61]. We 
hypothesize that functional MscL expression in these metastatic cancer cells in these 
contexts would lead to MscL activation and impairment of cancer cell migration. Our 
findings in our in vivo mice model showed that there was a marked reduction in 
metastasis to the lung for MscL expressing cancer cells compared to controls. In vitro 
migration experiments using a biomimetic microfluidic device revealed that MscL 
activation due to 3D-confined migration could be responsible for the observed 
reduction in metastasis as a significant proportion of cancer cells with activated MscL 









Functional Expression of Bacterial MscL in Mammalian Cells 
The majority of this chapter is directly modified from Heureaux et al., 2014 [62]. 
 
Introduction 
The first major effort of this thesis was to show that bacterial MscL from E. 
coli can be expressed in mammalian cells, localize to the plasma membrane, and 
respond to membrane tension. Doerner et al. were the first to work with MscL in 
mammalian cells, but did not explore MscL localization and mechano-sensing in 
detail[57]. We worked with retinal pigment epithelial (RPE) cells to investigate this. 
Using adenovirus, we obtained efficient and tunable expression of MscL in RPE cells. 
Immunostaining showed that MscL localizes to multiple cellular membranes, 
including the plasma membrane. To then test MscL WT and G22S mutant mechano-
sensing, we utilize osmotic down-shock. Based on MscL’s function as an emergency 
release valve in bacteria[54], we hypothesized that MscL could be activated in 
mammalian cells via membrane tension induced by osmotic down-shock. Working 
with larger mammalian cells that are easily imaged on epi-fluorescence microscopes 
compared to bacteria, allowed for the use of fluorescent dye uptake as a reporter of 
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MscL gating/activation. This means of detecting MscL activation was simple enough 
to be used as a functional assay in mammalian cells. 
 
Materials and Methods 
Adenoviral MscL Expression System in RPE Cells: Constructs for the E. coli 
MscL WT as well as the gain of function mutant, MscL G22S were kindly provided 
by Boris Martinac (Victor Chang Cardiac Research Institute, Darlinghurst, 
Australia). The MscL constructs were sub-cloned into a tetracycline (tet) regulatable 
adenovirus vector using seamless cloning PCR [63]. His6-tags were inserted at the N-
termini of the MscL sequences for subsequent immunofluorescence imaging and 
Western Blot analysis. All constructs were verified by DNA sequencing at the 
University of Michigan DNA Sequencing Core. Adenovirus was generated and 
harvested from human embryonic kidney 293 (HEK293) cells transfected with the 
pADtet constructs [64]. Retinal pigment epithelial (RPE) cells were maintained in 
DMEM/F12 supplemented with 10% fetal bovine serum. To express MscL, RPE cells 
were co-infected with the adenoviruses containing MscL WT or MscL G22S (an MscL 
mutant with lower activation threshold) with encoded tet regulatable promoter and 
tetracycline transactivator (tTA) adenovirus with incubation duration of 8 –16 h prior 
to all experiments. Addition of tetracycline of various concentrations during infection 
incubation periods was used to verify proper function of the adenovirus expression 
system. For immunofluorescence imaging, infected RPE cells were fixed, 
permeabilized, and labeled with anti-His antibodies (Pierce Antibodies, Rockford, IL). 
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Quantitative analysis of infrared Western blots was conducted utilizing a LI-COR 
Odyssey Sa system (Lincoln, Nebraska USA).  
Subcellular Fractionation of Cells: Cells from a 10-cm dish were lysed with 500 
µl of subcellular fractionation buffer (250 mM sucrose, 20 mM HEPES (7.4), 10 mM 
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 tablet of complete 
Protease Inhibitor Cocktail Tablets (Roche)), scraped and transferred to 
microcentrifuge tubes. The lysate was passed through a 25G needle 10 times and 
placed on ice for 20 minutes. To obtain the nuclear pellet, the tubes were centrifuged 
at 720 x g for 5 minutes and the supernatant was kept on ice. The nuclear pellet was 
washed 1X with the subcellular fractionation buffer. Supernatant from another 10-
minute 10,000 x g spin from the previous supernatant was further separated by 
ultracentrifugation at 100,000 x g for 1 hour, leaving the cytosolic fraction in the 
supernatant, and the membrane fraction in the pellet. All samples were resuspended 
in SDS sample buffer and MscL expression was detected by Western blot using anti-
His antibodies. 
Osmotic Down-shock Experiments: RPE cells were infected with the 
adenoviruses encoding MscL for 16 hours prior the osmotic downshock experiments. 
Cells were incubated for a period of 2 minutes in saline solutions of different 
osmolarity with 10 mM HEPES and 100 µM propidium iodide (PI) (Sigma-Aldrich, 
St. Louis, MO) or 1 µg/ml Alexa Fluor 568 phalloidin (Life Technologies, Carlsbad, 
CA). PI and phalloidin are both impermeable to the plasma membrane and label the 
nucleic acids and the actin cytoskeleton respectively upon entering the cells. After 
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incubation, cells were washed with 1X phosphate buffered saline (PBS) twice and 
fixed with 4% paraformaldehyde. The nucleus was labeled with DAPI after cell 
permeabilization. PI intensity was quantified and normalized to total cell area in 
solutions at varying osmolarity. Imaging was performed on a Nikon TiE inverted 




Expression of Bacterial MscL in Mammalian Cells: We first sought to develop 
a viral-based strategy for introducing MscL into mammalian cells (Figure 2.1A). WT 
and mutant MscL constructs with N-terminal His6-tag were cloned into a 
tetracycline-regulatable adenoviral vector. Infection with MscL-containing and 
tetracycline transactivator (tTA)-containing helper adenoviruses enables high 
expression efficiencies compared to transient transfection by using DNA vectors. 
Addition of tetracycline (tet) can tune the protein expression level by sequestering 
tTA. MscL expression in RPE cells infected with the adenoviruses containing MscL 
WT or MscL G22S exhibited a tetracycline dose dependent manner, as detected by 
both Western blot (Figure 2.1B), and immunofluorescence (Figure 2.1C). Nearly all 
the cells were infected and expressed MscL, and 50 ng/ml of tet was sufficient to turn 
off MscL expression. This experiment also served to validate our viral-based 
expression system for introducing MscL to mammalian cell lines. Since the His6-tag 
is present on the cytoplasmic side of MscL, cells were permeabilized for 
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immunofluorescence examination. Interestingly, in addition to staining the plasma 
membrane, staining of MscL near the nucleus was also observed. To further confirm 
this observed localization of MscL, cell fractionation was performed and MscL was 
found in both plasma membrane and the nucleus (Figure 2.1D). It was not 
immediately clear whether MscL was inserted in the double lipid bilayer of the 
nuclear envelope or just to the outer lipid bilayer of the nucleus. Note that a direct 
comparison of the levels of expression cannot be made because the strong Western 
blot bands of MscL in the nuclear membrane was due to more concentrated fraction 
compared to the plasma membrane fraction.  
Activation of MscL by Increasing Membrane Tension using Osmotic Shock: In 
E. coli, MscL and MscS subjected to an osmotic down-shock allows solutes to be 
released while maintaining cell viability. Cells with double null mutants are 
osmotically fragile[54]. Reconstitution of MscL into liposomes has demonstrated that 
MscL responds to membrane tension alone, and does not require any other proteins[21, 
65]. To determine if MscL introduced in mammalian cells can be gated similarly by 
osmotic pressure, we first tested if hypo-osmotic solution could gate MscL with 
fluorescent phalloidin included in the medium. The large size of MscL’s open pore 
allows free passage of large organic osmolytes. Phalloidin is ~800 Da and binds 
strongly to filamentous actin (F-actin) and not to monomeric actin. Furthermore, 
fluorescent phalloidin labels the F-actin strongly and is non-fluorescent when not 
bound to actin. Using this assay, we found that for RPE cells not expressing MscL, 
there was no phalloidin staining under both iso-osmotic and hypo-osmotic (10 mM  
 25 
  
Figure 2.1 Viral Expression System for Mammalian Cells. (A) An adenovirus-based system for tetracycline-
controlled transcriptional activation of MscL expression which consists of co-infection of tetracycline 
transactivator (tTA) and MscL viruses. In the absence of tet, tTA binds to the tet-op promoter upstream of the 
MscL gene and induces expression. In the presence of tet, tTA is sequestered, inhibiting expression of MscL. (B) 
Western blot analysis of infected whole cells and (C) fluorescent images of immunostained His-tagged MscL in 
mammalian cells cultured at different concentration of tetracycline. Scale bar = 25 µm. (D) Western blot analysis 
of fractionated cells showing MscL subcellular localization. (E) Confocal micrographs of immunostained His-
tagged MscL in RPE cells. Scale bar = 25 µm 
 
HEPES) conditions, as expected (Figure 2.2A). In RPE cells with expressed MscL, 
strong phalloidin staining was observed in cells that were under hypo-osmotic 
condition but not in iso-osmotic condition. Together, these results confirmed the 
functional expression of MscL in RPE cells.  As a non-selective channel that molecules 
up to 6.5 kDa in size can permeate through, other osmolytes can also transit through 
the opened MscL [66]. 
To further investigate the responsiveness of MscL activation by osmotic 
pressure, we used PI, an intercalating fluorescent molecule when bound to nucleic 
acid after entering the cells, to determine the threshold of MscL activation. Some dye 
uptake was evident at 100 mOsm and the influx continued to increase with 
E. 
Anti-His MscL WT  
DAPI Nucleus 
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decreasing solution osmolarity. As expected and consistent with the earlier result, no 
PI uptake was detected at any osmolarity when RPE cells did not express MscL 
(Figure 2.2B, C). At the low end of the osmolarity, cells expressing MscL G22S took 
up significantly more PI than MscL WT cells. Interestingly, it appeared that MscL 
WT had a more dye uptake or more activation than MscL G22S. In addition, since 
MscL was found to localize to the nuclear membrane as well, we asked whether 
osmotic down-shock would affect the nucleus. Since PI binds strongly to nucleic acid, 
presence of PI labeling in the nucleus does not necessarily indicate that MscL is 
functioning in the nuclear membrane. Under iso-osmotic conditions, nuclei sizes were 
similar between control cells and cells expressing MscL. The nuclei of MscL 
expressing cells were smaller under hypo-osmotic conditions for both WT and G22S 
mutant (Figure 2.2D), suggesting that MscL could be activated on nuclear membrane 
as well. The increase in osmotic pressure in hypo-osmotic solution arises from the 
tendency of water to cross the cell membrane, which increases cell volume, and 
thereby membrane tension.  
Osmotic down-shock experiments were also performed on Chinese Hamster 
Ovary (CHO) cells expressing MscL WT and G26C cells (courtesy of Doerner et al. 
[57]) (Figure 2.2E) and compared to MTSET activation. The CHO MscL WT cells 
showed higher PI uptake for 175 mOsm and 10 mOsm than CHO MscL G26C cells 
indicating that MscL WT is more mechanosensitive than MscL G26C in CHO cells. 
CHO MscL G26C cells showed robust uptake of PI when chemically activated with 
1mM MTSET in media for 8 minutes while MscL WT cells showed no uptake. 
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Figure 2.2 Osmotic Down-shock Experiments on MscL Expressing RPE and CHO cells. (A) Cartoon description of 
osmotic shock assay (top). Under hypo-osmotic conditions, mammalian cell membranes swell leading to increased 
E. 
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membrane tension and MscL activation, which allows for uptake of fluorescent phalloidin. Fluorescent images of 
fixed, MscL WT infected and non-infected cells incubated under iso-osmotic and hypo-osmotic solution containing 
fluorescent phalloidin for 8 minutes (bottom). F-actin labeling is shown in red and DAPI labeling in blue. (B) 
Fluorescent images showing PI (red) uptake in cells expressing MscL WT and G22S and in non-infected cells. (C) 
Average PI uptake after two minutes incubation with PI solutions of decreasing osmolarity (n=3, ncell per condition 
is ~100). (D) Average nucleus area of non-infected cells and those expressing MscL WT and G22S in iso-osmotic 
and hypo-osmotic conditions (n=3, ncells = ~100). Error bars are standard error of the mean. (E) Fluorescent images 
showing PI uptake of MTSET condition and osmotic down-shock performed on CHO cells expressing MscL WT 
and MscL G26C. Scale bars = 25 μm. 
 
Discussion 
Our finding that MscL was localized to nuclear membrane of the infected RPE 
cells, in addition to the plasma membrane, and presumably also to other cellular 
compartments, is interesting. This may not be entirely surprising given that MscL 
does not have a leader sequence targeting it to the plasma membrane. Thus, it may 
be able to insert into any cellular membranes as it readily inserts into liposome 
bilayers, and leading to interesting consequences. For example, expression of MscL 
in mammalian cells was found in this study to be responsible for the influx of small 
molecules such as PI and phalloidin during an osmotic down-shock. Remarkably, 
osmotic down-shock also decreased nuclei sizes. The precise mechanism of how this 
occurred is unclear, but the possibility that MscL could potentially alter the 
mechanics of the nucleus is intriguing and further studies are required to determine 
if nuclear functions are affected by MscL activation from osmotic downshock.  In cells 
expressing MscL G22S, significantly higher PI uptake was observed with the 
strongest osmotic down-shock tested compared to MscL WT, but more uptake was 
observed for MscL WT than MscL G22S for the other, less extreme hypo-osmotic 
conditions. Potentially, there could be differences in the activation of the two MscL 
molecules that resulted in different opening states such as channel kinetics, and/or 
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sub-conducting states and thresholds. A possible mechanism is the differences 
between the closed expanded state and the tendency for GOF mutants to prefer lower 
sub-conducting states until triggered by a higher tension range [27]. Though this was 
not previously observed for MscL G22S mutant specifically, it has been observed in 
other gain of function mutants, and there is still a possibility that this can be true in 
our mammalian cell system. Given that MscL G22S is more sensitive to tension, it 
may silently expand sooner than WT MscL, which in turn would relax membrane 
tension due to the low osmolarity. This would result in MscL G22S appearing to open 
at a higher tension/lower osmolarity threshold than MscL WT. MscL G22S also 
exhibits flickering kinetics (i.e., dwell times ~2 ms) that can also result in a reduction 
in uptake. 
The results from the osmotic down-shock experiment on CHO cells expressing 
MscL WT and G26C appear to be in direct contrast with what has been found 
previously in spheroplasts where MscL G26C had a tension threshold ~0.76x of MscL 
WT making it a gain of function mutant [67]. However, MscL G26C channel kinetics 
under tension activation is < 1 ms and MscL WT kinetics vary from < 1 ms to 30 ms. 
The MscL G26C flickering kinetics can result in a reduction in the amount of dye that 
can pass through the channel similar to what was observed with MscL G22S. 
 
Conclusions and Implications 
In summary, we were able to show successful expression of MscL in RPE cells 
and MscL localization to multiple cellular membranes including the plasma 
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membrane. MscL mechano-sensing was retained and the channel could be activated 
by osmotic down-shock. For our experiments, we used visualization of dye uptake as 
an indicator of MscL activation and we found that dye uptake correlated to the extent 
of osmotic shock. Finally, we found that MscL activity is increased with the G22S 
mutant for more extreme shock (e.g., ~10 mOsm in our experiments). 
Our findings have already led to impactful implications. The method of osmotic 
down-shock was simple and robust enough to be used as a functional assay of MscL 
in mammalian cells. Using dye uptake as a qualitative reporter of MscL activation in 
mammalian cells is more accessible than traditional means such as patch-clamp 
electrophysiology. Importantly, we show that osmotic shock activation of MscL can 
be used to deliver large and impermeable molecules into living cells, which can be 
used as a tool for many scientific applications not exclusive to the field of 
mechanobiology.  
Activation of MscL via osmotic down-shock now leads us into investigating 
activation of MscL in mammalian cells via other types of mechanical perturbation. 
By doing so, we can expand MscL’s mechano-sensing repertoire for mammalian cells 








Activation of MscL in Mammalian Cells via Different Modes of Mechanical 
Perturbation and Linking MscL Activity to the Cytoskeleton 
 
The majority of this chapter is directly modified from Heureaux et al., 2014 [62]. 
 
Introduction 
The importance of cytoskeleton for activating endogenous mammalian MS 
channels has been suggested by many studies [68-70]. This is in contrast to bacterial 
MS channels that do not require the bacterial cytoskeleton to function. Although 
neither MscL nor MscS homologues have been identified in animal and human cells 
to date, reconstitution of functional MscL activity in mammalian cells was recently 
demonstrated [57]. This revealed that MscL mechanical activation via pressure 
modulated patch clamp is possible and molecular transport can be achieved by 
charge-induced activation of mutant MscL G26C. Even though there is a well-
accepted mechanism for MscL activation by membrane tension in bacteria, whether 
and how MscL can be opened by other modes of force transduction in mammalian 
cells were not investigated. The ability to express MscL in mammalian cells presents 
new opportunities for studying the activation mechanism of MscL and potentially can 
introduce new mechanostransduction pathways to mammalian cells. In this study, 
we examined MscL function under different mechanical perturbations in mammalian 
cells. We performed micropipette aspiration of single cells and fluid shear stress 
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experiments to characterize these channels in RPE, mammalian cells. Both methods 
failed to gate MscL under our experimental conditions. Interestingly, using a 
relatively new technique, acoustic tweezing cytometry (ATC) [71], where acoustic 
excitation of lipid-coated microbubbles targeted to the cell membrane via integrin 
receptors, robustly gated MscL and the ATC-mediated activation was dependent on 
an intact cytoskeleton and the coupling to integrin receptors. Our results 
demonstrate that the activation of a bacterial MS channel expressed in mammalian 
cells can be mediated through localized membrane stress that is dependent on the 
actin cytoskeleton. 
 
Materials and Methods 
Adenoviral MscL Expression System in RPE Cells: Refer to Chapter II. 
Micropipette Aspiration: Aspiration was applied by a homebuilt micropipette 
aspiration system with a graduated manometer and an in-line DP15 pressure sensor 
(Validyne Engineering, Northridge, CA). Shortly before aspiration, RPE cells 
expressing MscL or not were lifted by incubation with citric saline. The cells were 
spun down and resuspended in culture medium.  The suspension and 50 µM PI were 
then added to a custom viewing chamber. Glass micropipettes with inner diameters 
of 5 µm were filled with 0.2% bovine serum albumin (BSA) in PBS in order to allow 
smooth movement of cell membrane inside the pipette. Negative pressure in the 
micropipette tip was generated by aspirating water from the main manometer 
reservoir and increased gradually in 100 Pa increments. Sudden pressure shock was 
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applied to aspirated cells by manually tapping the tubing attached to the 
micropipette. Nikon Advanced Modulation Contrast optics (NAMC) mounted on a 
Nikon Ti-S microscope and CoolSnap MYO CCD camera (Photometrics, Tucson, AZ) 
were used to acquire live-cell bright-field and fluorescent images. 
Shear Flow Experiments Cells: were seeded in µ-slide VI0.1 microfluidic 
channels (ibidi, Verona, WI) overnight prior to infection with MscL adenoviruses. A 
60-mL plastic syringe containing 50 µM propidium idodide in DMEM/F12 medium 
was mounted to a HA PhD Ultra syringe pump (Harvard Apparatus, Holliston, MA) 
and connected to the microchannels using sterilized Tygon tubing and Luer fittings. 
Shear stress in the channels was controlled by varying the flow rate. The shear stress, 
𝜏 (in dyne/cm2), as a function of volumetric flow rate, Q (in µl/min), is 𝜏 = 0.1067𝑄 for 
a fluid viscosity of 0.01 dyne/cm2 (per manufacturer’s application note). Each channel 
was exposed to a fluid shear stress for 4-5 minutes. Live cell microscopy was 
performed on the Nikon Ti-E inverted fluorescence microscope equipped with sCMOS 
camera (Hamamatsu Photonics) and controlled via µManager software 
(http://www.micro manager.org). 
Acoustic Tweezing Cytometry (ATC) Experiments: A similar ATC setup 
described previously was used in this study [71]. One day prior to ATC, RPE WT cells 
were seeded on glass bottom culture dishes (MatTek Corporation, Ashland, MA) 
coated with 50 µg/mL fibronectin from human plasma (Sigma-Aldrich, St. Louis, MO). 
Right before ATC experiments, Targesphere™-SA microbubbles (Targeson, San 
Diego, CA, USA) were mixed with biotinylated Arg-Gly-Asp (RGD) peptides (Peptides 
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International, Louisville, KY, USA) for 20 min at room temperature, with a volume 
ratio of 5:1 of microbubbles (5x108 mL-1) to RGD (0.01 mg/mL). To attach the 
microbubbles to cells, the culture media from the cell-seeded 35 mm glass bottom dish 
was removed followed by immediate addition of 20 μL of microbubble-RGD mixture.  
The small fluid volume permitted inversion of the culture dish to allow 
microbubbles to float upward to facilitate attachment of the microbubbles to the cells 
via RGD-integrin bindings. After 10 min, the dish was flipped back and unbound 
microbubbles were removed by a gentle wash with culture media. During 
experiments, the cell-seeded dish was placed on a 37°C heating stage on an inverted 
microscope (Eclipse Ti-U; Nikon, Melville, NY, USA). A 40× objective (0.75 NA; 
Nikon, Melville, NY, USA) was used for observation of cells and microbubble 
activities. A 10 MHz focused transducer (Olympus, Waltham, MA, USA) was 
positioned at an incident angle of 45° to apply ultrasound pulses to excite the 
microbubbles attached to the cells. The transducer was driven by a waveform 
generator (Agilent Technologies 33250A, Palo Alto, CA) and a 75 W power amplifier 
(Amplifier Research 75A250, Souderton, PA). The ultrasound pulses applied in this 
study each had a fixed pulse duration (PD) of 50 ms and pulse repetition frequency 
(PRF) was 5 Hz. The total duration of ultrasound application was 10 s with the 
acoustic pressure amplitude of the ultrasound pulses as a variable. The free field 
acoustic pressure was measured using a 40 μm calibrated needle hydrophone 
(Precision Acoustics HPM04/1, UK). The application of ultrasound was synchronized 
with a high-speed camera (Photron FASTCAM SA1, San Diego, CA), which was used 
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to capture the ultrasound-driven microbubble activities at a frame rate of 5,000 
frames/s. The translational displacement and the radius of the microbubbles before, 
during, and after ultrasound application were obtained from the high-speed image 
sequences using a custom MATLAB program. Only cells with bound microbubbles 




Micropipette Aspiration of MscL Expressing RPE Cells: To see if cortical 
tension alone, without the concomitant increase in cell volume (like that observed 
during the osmotic down-shock experiments), could activate MscL, we utilized 
micropipette aspiration to manipulate cortical tension of RPE cells in suspension. The 
suction pressure is typically small relative to the osmotic pressure of the isotonic 
media, so the cell will deform without an apparent increase in volume. Here, 
micropipettes with inner diameters of 5 µm were used on RPE cells which have an 
average apparent diameter of 15 µm. Our custom micropipette aspiration setup was 
able to apply aspiration pressures of up to ~ 1 kPa. By including PI in the external 
medium, activation of MscL by micropipette aspiration was tested (Figure 3.1A). We 
did not observe PI uptake into both MscL WT and G22S cells for the full range of our 
aspiration pressure (Figure 3.1B). However, when a sudden change in pressure was 
introduced by gently tapping the tubing connecting to the pipette, PI uptake was 
observed for every condition, including cells without MscL, suggesting that the 
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sudden pressure shock may have led to transient membrane disruption. To contrast 
the previous osmotic down-shock experiments, a spread RPE cell can easily cover > 
1500 µm2 area, suspended RPE cells may have significant amount of membrane 
reservoirs within the membrane folds. Thus, the aspiration pressure applied may not 
be able to significantly increase cortical tension, as one would initially expect. 
Shear Stress by Fluid Flow: Mechanochemical signal transduction by shear-
sensitive mechanoreceptor allows sensing of hemodynamic forces, particularly in 
endothelial cells [72]. We next asked whether shear stress could possibly activate MscL 
in mammalian cells. Shear stress can be controlled using microfluidic channels with 
well-defined geometry (Figure 3.2A). While the cultured cells in microchannels 
expressed MscL successfully (Figure 3.2B), no robust MscL activation was detected 
in cells subjected to shear stress up to 400 dyne/cm2 (Figure 3.2C). At 400 dyne/cm2 
of shear stress, a few cells expressing MscL G22S were observed with PI uptake, but 
cell detachment was evident when shear stress above 400 dyne/cm2 was applied, as 
others have shown [73]. As a positive control, MscL expressing cells in microfluidic 
channels took up PI when subjected to an osmotic down-shock (Figure 3.2D). Because 
the fluidity of the lipid bilayer membrane, flow-generated shear stress is unable to 




Figure 3.1 Micropipette Aspiration. (A) Cartoon of micropipette aspiration on MscL expressing mammalian cells. 
(B) Brightfield and corresponding fluorescent images showing PI uptake for a MscL WT expressing cell as applied 
aspiration pressure is increased (i – iii). The edge of the cell protrusion drawn into the micropipette is indicated 
by yellow arrows. Pressure shock is applied to the cell when the tubing directly connected to the micropipette is 



















































































































































































































































































































































































































































Acoustic Tweezing Cytometry and Direct Linkage to the Mammalian Cell 
Cytoskeleton: Shear deformation becomes relevant if the membrane is coupled to 
structures such as the cytoskeleton. To test if localized stress to the cells could 
potentially induce activation of MscL expressed in mammalian cells, we conducted a 
series of experiments using acoustic tweezing cytometry (ATC) (Figure 3.3A). ATC 
uses ultrasound pulses to excite gas-filled microbubbles that were functionalized with 
Arg-Gly-Asp (RGD) peptide and attached to integrin receptors of the cells via the 
robust interaction of ultrasound with the integrin-anchored microbubbles [24]. 
Ultrasound pulses generate a directional force, the acoustic radiation force [74], on the 
microbubbles, and the displacement of the integrin-anchored microbubbles from their 
original location leads to targeted stress to the cells through the microbubble-integrin 
cytoskeleton linkage. In addition, ultrasound application readily generates cavitation 
of the microbubbles (rapid volume expansion and contraction), which induced 
microstreaming of fluid, thus shear stress, near the microbubbles [75]. Our previous 
work has shown that ATC using ultrasonic excitation of RGD-functionalized 
microbubbles bound to integrins elicited strong cytoskeleton contractile response that 
required an intact actin cytoskeleton and Rho/ROCK signaling [71]. In this study, 
functionalized microbubbles were introduced to cells seeded on a glass bottomed 
culture dish such that 3.7 ± 2.2 (n = 40 cells) microbubbles were attached to each of 
the cells (Figure 3.3B). Using a 10 MHz transducer mounted at a 45o angle, 
microbubbles were subjected to 10 s of application of ultrasound pulses with a duty 
cycle of 25% and pulse repetition frequency of 5 Hz. These parameters minimized the 
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cavitation effect compared to the directional force (acoustic radiation force) exerted 
on the microbubbles. The primary acoustic radiation force was generated by the 
incident ultrasound field on a microbubble via momentum transfer, and can be 






 [74], where PA is the acoustic pressure 
amplitude, R0 is the equilibrium radius of microbubble, δtot is the total damping 
constant (0.1), ρ0 is the medium density (1000 kg/m3), and c is the speed of sound in 
medium (1500 m/s), ω0 = 2 πf0, where f0 is the resonance frequency (3.5 MHz) of the 
lipid coated microbubble with a radius of 2 µm [76], and ω is the frequency of the 
ultrasound applied (10 MHz). 
Using a pressure amplitude between 0.047 MPa and 0.095 MPa, a force 
between 15 pN and 60 pN can be generated on a microbubble (Figure 3.4). Large 
amplitude expansion/contraction of microbubbles (strong cavitation), which typically 
occurs under high acoustic pressures or when the frequency of the incident 
ultrasound field is close to the resonant frequency of the microbubbles, can lead to 
transient membrane disruption by sonoporation that permits transport of exogenous 
molecules [77]. Large amplitude cavitation often leads to reduction in microbubble size 
over time, due to gas leakage from the disrupted protective lipid layer of the 
encapsulated microbubbles. To ensure cavitation was not the cause for PI uptake by 
disrupting the cell membrane in our experimental study, we employed relatively low 
acoustic pressure amplitudes and 10 MHz center frequency, which was far away from 
the microbubble resonant frequency. High-speed imaging observation confirmed that 
microbubble expansion and contraction was minimal (< 5% of the equilibrium radius) 
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Figure 3.3 Acoustic Tweezing Cytometery for Activation of MscL in Mammalian Cells and Uptake of Impermeable 
Molecules. (A) Experimental setup of ultrasound excitation of targeted microbubbles attached to the membrane 
of cells (drawing not to scale). (B) Brightfield image of an RPE cell outlined in yellow witch RGD functionalized 
microbubbles attached indicated by yellow arrows. (C) Ultrasound- (US) induced microbubble activities. Typical 
translational displacement and radius profile of a microbubble during the 10-second US stimulation (pulse 
duration = 50 ms, pulse repetition frequency (PRF) = 5 Hz, Acoustic pressure = 0.071 MPa). (D) Fluorescent 
images of MscL WT, MscL G22S, and non-infected cells with RGD-microbubbles subjected to different radiation 
forces. Cells with PI uptake after US application exhibit bright fluorescence. (E) Delivery rate (percentage of cells 
with PI uptake after US application) of MscL WT, MscL G22S, and non-infected cells with integrin-bound, RGD-
microbubbles (n = 3 - 5, ncell = 100 - 400).  (F) Fluorescent images showing PI uptake after US application for MscL 
WT infected cells not treated and treated with 50 nM latrunculin A with RGD-microbubbles, and cells infected 
with MscL WT and bTfnR adenoviruses with avidin functionalized microbubbles bound to biotinylated-transferrin 
receptors. (E) Delivery rate for MscL WT infected cells not treated and treated with 50 nM latrunculin A with 
with integrin-bound microbubbles and MscL\bTfnR infected cells with biotinylated-transferrin receptor-bound 
microbubbles (n = 3, ncell = ~100 - 300). Scale bars = 25 µm for (B), (D), and (F). One-tailed t-test comparing MscL-
expressing vs. non-infected cells showed significant differences between all conditions (p < 0.05), except for 15 pN. 
Error bars are standard error of the mean. 
 42 
and the size of microbubbles remained stable throughout ultrasound application 
(Figure 3.3C). Furthermore, experiments with PI in the medium showed no uptake 
in the control cells (without MscL), with or without microbubbles, indicating no cell 
membrane disruption by ultrasound application. Translational displacement of the 
microbubbles was observed with an average displacement of ~ 1 µm achieved during 
each ultrasound pulse. During the pulse-off period, the microbubbles partially 
returned to their original positions, dictated by the elastic properties of the 
microbubble-focal adhesion-cytoskeleton linkages.  
 
Figure 3.4 Radiation Force Applied to Microbubbles. Shown as a function of ultrasound pressure produced by 
the 10 MHz transducer for the ATC system used. 
 
The creep in the displacements may be due to the short time interval between 
pulses such that there may not be enough time for a full recovery of microbubble 
displacements.  Interestingly, with application of ATC to apply forces to the integrin 
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receptors, cells expressing MscL clearly took up PI as the acoustic radiation force 
increased from 0 to 60 pN, in contrast to uninfected cells without visible PI uptake 
(Figure 3.3D), indicating gating of the MscL expressed in the cells by ATC 
stimulation. The percentage of cells that took up PI increased to up to about 20%, and 
MscL G22S expressing cells had a higher percentage of cells with PI uptake compared 
to MscL WT cells (about 14%), consistent with the lower tension threshold for MscL 
G22S expressing cells (Figure 3.3E).  To exclude the possibility that virus-infection of 
cells somehow caused the cells to become more sensitive to ATC perturbation, we 
tested whether RPE cells expressing adenovirus-encoded biotinylated transferrin 
receptor (bTfnR) using a site-specific labeling approach developed previously [78] took 
up PI when subjected to ATC stimulation. We found that bTfnR expressing RPE cells 
did not take up PI at any applied forces by ATC, indicating that the viral infection 
had no effect on PI uptake. As RGD-bound microbubbles were targeted to integrin 
receptors, we tested whether MscL activation could occur by forces applied to other 
membrane receptors such as bTfnR. With microbubbles bound to cells expressing 
both bTfnR and MscL, we found no PI uptake in these cells subjected to the same 
ATC stimulation (Figure 3.3F), suggesting that force transduction through the 
integrin-focal adhesion complex is critical for the observed activation of MscL and PI 
uptake by ATC stimulation. Consistently, mild disruption of the actin cytoskeleton 
by treating the cells with 50 nM of latrunculin A, an actin monomer binding drug, 
reduced the PI delivery rate significantly (Figure 3.3G). Together, these results 
showed that the observed activation of MscL is mediated through localized 
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mechanical stress induced by ultrasound actuation of integrin-anchored 
microbubbles on the cells via the microbubble-integrin-cytoskeleton linkage in an 
actin dependent manner. 
 
Discussion 
Mechanosensation is one of the most ubiquitous phenomena in living systems 
and MS channels constitute the simplest mechanism of mechanotransduction [79]. 
However, our understanding of MS channels is far from complete. Studies of 
mechanosensation in bacteria have led to the discovery of MS channels that gate by 
lipid bilayer tension, while identification of the gating mechanisms of MS channels 
in eukaryotes has been much more challenging due to the rarity of certain sensory 
cells and the difficulty in assaying the function of candidate mechanotransudction 
molecules[80]. Our results presented in this study identified a new activation 
mechanism for gating MscL in a different cellular context, by employing a new 
cellular mechanics tool (ATC) and on mammalian cells expressing bacterial MscL.  
Our current study using micropipette aspiration setup indicated that up to ~1 kPa of 
aspiration pressure was insufficient to activate MscL in RPE cells. We found that the 
RPE cells behaved more like an elastic solid than a liquid droplet as it was possible 
to apply aspiration pressures to have Lp / Rp > 1 in our experiments, where Lp is the 
aspiration length and Rp is the micropipette radius, without causing the cell to be 
completely aspirated into the micropipette. The equivalent cortical tension for solid 
cells at the point Lp / Rp = 1 is ~ 2.2 ERp [81], where E is the Young’s modulus. Using 
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E as 500 pN/µm2 and Rp of 5 µm, the cortical tension is 5.5 mN/m. This tension is 
about half of the membrane tension of ~10-12 mN/m reported to gate MscL when 
reconstituted in liposome [82, 83]. However, since our suction pressure was an order of 
magnitude smaller than what was found to gate MscL in mammalian cells, ~13 kPa 
in CHO or HEK cells [57], we believe the cortical tension did not increase significantly 
past the point Lp / Rp = 1 in our experiments. This could be due to a significant 
membrane reservoir of the RPE cells in suspension that buffered changes to 
increasing suction pressure. Additional studies are needed to determine exactly the 
cortical tensions generated in the RPE cells during micropipette aspiration to obtain 
better understanding of the gating threshold of MscL in these cells. 
Our experiments also showed that MscL in RPE cells was not sensitive to flow-
induced shear stress up to 400 dyne/cm2. At 400 dyne/cm2, a surface tension of up to 
0.1 mN/m could be induced for a 25 µm cell, which was much lower than the reported 
~12 mN/m for MscL activation [83]. Thus, the inability for shear stress to open MscL 
in our experiment may be primarily due to the insufficient membrane tension to gate 
MscL that is produced by fluid flow. Increasing the flow velocity to increase shear 
stress was not feasible in our experiments due to cell detachment, indicating the 
limitation of the use of flow-induced shear stress as a robust mechanism for gating of 
MscL expressed in RPE cells. As such, shear-sensitive MS channels could have a very 
different gating mechanism than sensing pure membrane tension as the primary 
stimulus. For example, tethering to the cytoskeleton may be important in the 
activation mechanism for shear-sensitive MS channels. MS channels gating is 
 46 
employed in hair cells and neuronal cells which have a direct connection between the 
channels and the cytoskeleton and/or extracellular matrix (ECM) in order to confer 
directional sensitivity [80, 84]. Furthermore, a recent work postulates that stiffened 
lipid platforms that can direct, rescale, and confine force may be a plausible 
mechanism that is used by mammalian cells [85]. This is an interesting possibility 
because cell membranes are highly heterogeneous and cells have extensive 
cytoskeleton networks that connect to the ECM through transmembrane integrin 
receptors. Since cytoskeleton membrane interaction plays a key role in regulating 
membrane properties, cytoskeleton and ECM may serve to modulate the dynamic 
range in gating of MS channels [86]. The use of the novel ATC technique for applying 
mechanical forces provided the opportunity to investigate the involvement of this 
mechanism in MscL gating. Our finding that local force application using ATC could 
open MscL in an actin-dependent and integrin-dependent manner supports this idea, 
and is consistent with a previous study that showed direct mechanical stimulation of 
actin stress fibers activates MS channels in endothelial cells [68],where a stretching 
force of 5.5 pN exerted on stress fibers resulted in inward current from MS channels 
[68]. In this study and indicated by previous work, ATC applied local mechanical 
stresses to the cells via acoustic actuation of integrin-bound microbubbles. Although 
the detailed process of force generation on the cells is the focus of on-going 
investigations, it is clear that the displacements of the integrin-bound microbubbles 
by the acoustic radiation force are involved in the stress exerted to the cells. On the 
other hand, fluid microstreaming induced by a cavitating microbubble during 
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ultrasound application can also exert localized shear stress on the nearby cells, as 
demonstrated previously [75]. However, in this study, the use of low acoustic pressures 
and center frequency of 10 MHz likely reduced the impact of cavitation relative to 
microbubble displacement. While the force that we applied to the microbubbles 
corresponding to activation of MscL ranged from 30 – 60 pN, how this force is 
translated to the cells to contribute to gating MscL requires further investigation. In 
addition, the effects of the number of microbubbles and duration of ATC stimulation 
will need to be elucidated.  Nonetheless, the forces we applied to cells by the use of 
ATC to open MscL is likely greater than the 0.5 pN force that is exerted by a globally 
applied shear stress of 400 dyne/cm2, assuming a protein of 5 nm in diameter. More 
importantly, we believe it is the localized force transduction via the microbubble-
integrin-actin cytoskeleton that was critical for the gating of MscL. The finding that 
exerting the same force using ATC on microbubbles targeted to TfnR did not gate 
MscL supports the idea that force transduction via integrin actin cytoskeleton is 
responsible for the observed MscL gating. Interestingly, there are no known 
molecular interactions between MscL and any mammalian cellular components, thus 
force transduction via cytoskeleton is highly unlikely to act through a direct tethering 
mechanism that has been proposed to pre-stress MS channels and affects their 
sensitivity [87].  
Instead, we believe that a local change in membrane tension was generated by 
ATC and gated MscL in our experiments, revealing a new mechanism for gating MscL 
in mammalian cells. Our ATC experiment also provides the first demonstration 
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where delivery of molecules across the cell membrane can be achieved through the 
activation of a non-specific MS channel without transient membrane disruption 
through sonoporation, providing an intriguing mechanism for intracellular molecular 
delivery. The use of ultrasound in ATC is advantageous as it can exert forces on 
multiple cells at the same time via biocompatible and multifunctional microbubbles 
in both 2D or 3D settings with a force range that is compatible with biological studies. 
Our results reported in this study demonstrate a new platform for further 
investigating MscL gating under different cellular conditions. The ability to 
functionally express MscL in mammalian cells could provide new opportunities for 
mechanobiology studies. MscL expression in non-mechanosensitive cells can render 
them mechanosensitive and be used as a novel mechanism for molecular delivery in 
these cells. A number of diseases such as muscular dystrophy, sickle cell anemia, and 
cardiac arrhythmias have been linked to defects in activating MS channels. Thus, it 
is tantalizing to suggest that engineered MscL with precise gating behaviors could be 
used as a therapeutic tool. Finally, one could also imagine the potential of using MscL 
in building functional cellular devices that are mechanosensitive. mechanism for 
gating MscL in mammalian cells. Finally, one could also imagine the potential of 
using MscL in building functional cellular devices that are mechanosensitive. 
 
Conclusions and Implications 
In summary, we were unable to robustly activate MscL in RPE cells using 
shear flow on adherent cells and micropipette aspiration likely due to insufficient 
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membrane tension. However, ATC on RPE cells expressing MscL WT and G22S 
resulted in MscL activation where MscL G22S was more responsive to ATC. 
Activation was contingent on (1) microbubbles being bound to integrins (i.e., integrins 
were directly perturbed) and (2) an intact actin cytoskeleton. 
Here we show how MscL and ATC can be used to deliver impermeable 
molecules into living cells without the need for bubble cavitation. Importantly we 
postulate a model for native integrin-actin cytoskeleton and MscL interaction where 
direct perturbation of actin-linked integrins can result in enough localized membrane 
force to activate MscL in mammalian cells (Figure 3.5) 
 
Figure 3.5 Postulated Model for Native Integrin-Actin Cytoskeleton and MscL Interaction in Mammalian Cells. 
 
Having shown robust activation of MscL in mammalian cells due to osmotic 
down-shock and integrin-actin perturbation, we look into MscL’s effect on cellular 
function – the output of mechanotransduction. We focus on cell migration in cancer 
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metastasis and then more specifically, 3D-confinements. During the physiological 
process of metastasis, cancer cells migrate through narrow pores and channels 
undergoing significant deformation[58, 59]. Moreover,  in these 3D confined spaces 
cancer cells have been shown to utilize motility mechanism that rely on the actin-
cytoskeleton and myosin[60], or native aquaporins and ion channels[61]. We 
hypothesize that functional MscL expression in these metastatic cancer cells in these 






Expression of MscL in Mammalian Metastatic Cancer Cells for Study and 
Disruption of Migration in Narrow 3D Confinements 
 
Introduction 
Cancer metastasis, the migration and spread of cancer cells from primary 
tumors through the vasculature and lymphatic system to secondary tissues and 
organs, involves extreme physical deformation of tumor cells with cross-sectional 
areas of ~200 μm2 through narrow paths and pores with cross-sectional areas of 10-
300 μm2 [59, 88, 89]. Such extreme deformation occurs mainly at the intravasation and 
extravasation steps and when migrating through dense regions of extracellular 
matrix in the metastatic cascade [90, 91]. Despite these apparently harsh physical 
obstacles on tumor cells, metastasis can persist, turning something like a non-life-
threatening breast tumor into a multi-organ disease. This process of in vivo cancer 
cell migration and translocation continues to be the cause of an estimated 90% of 
cancer related fatalities [91-93]. 
The severe implications of metastasis have led to many investigations of cancer 
cell migration and development of various models of migration to help elucidate key 
aspects of metastasis. Emphasis of such research has diverted more and more from 
studying migration in 2D, planar environments where migration is dependent on 
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actin polymerization and polarization, Rho/ROCK myosin II contractility, 
integrin/matrix adhesion, and protrusion of lamellipodia type structures of the cell 
[94]. Work in 3D in vitro platforms, which aim to be more physiologically relevant, 
exhibit variability depending on the specific properties of the substrate and cell type. 
These migration models now incorporate not just the cytoskeleton components, but 
also metalloproteases, nucleoskeleton, intermediate filaments, and nuclear linker 
proteins [95-97]. 
Moreover, it has been recently demonstrated that cancer cell migration within 
confined 3-dimensional microfluidic channels is mediated by directional water 
permeation across the cell [61, 98, 99]. The over expression of aquaporins, AQ5, and 
sodium/hydrogen exchangers at the cell membrane, and their reorientation in cancer 
cells results in an “osmotic engine” propulsion system in which the cancer cells can 
have a net influx of water at their leading edge and net efflux of water at their trailing 
edge. This mode of migration was found to occur under extreme confinement, 30 µm2, 
and is independent of cytoskeletal components [98], showing a novel model and 
mechanism for cancer cell migration and metastasis.  
Previously, it was shown that an exogenous, bacterial channel protein, 
Mechanosensitive channel of large conductance (MscL), can be functionally expressed 
in mammalian cells [57, 62]. MscL is activated via membrane tension and deformation 
with a gating threshold of ~10.4 mN m−1 and gain of function mutant, MscL G22S 
with ~5-6 mN m−1 [22, 23, 43, 79]. MscL also has a large pore of ~3 nm diameter and is 
nonselective, allowing the bidirectional passage of any large osmolytes ≤ 10,000 Da 
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in size [51-53].The extreme deformation of the cancer cells through the metastatic 
cascade, in particular migration through narrow 3D confinements, is anticipated to 
result in MscL activation at the plasma membrane.  
Here we hypothesize that MscL activation during the metastatic process will 
result in disruption and reduction of metastasis of tumor cells. To investigate MscL’s 
effect on cancer metastasis and 3D confined migration, we developed stable 
metastatic breast cancer cell lines, MDA-MB-231, with gain of function mutant MscL 
G22S. We studied cell metastasis and primary tumor growth in vivo with an 
immunodeficient mice model and then, in greater detail, cancer cell migration in 
various channel cross-sections to mimic different degrees of confinement in an in vitro 
microfluidic platform.  
 
Materials and Methods 
Cells: MDA-MB-231 human breast cancer cells and 293T cells (ATCC) were 
cultured in DMEM (Thermo Fisher) with 10% bovine serum, 1% penicillin, 
streptomycin, and glutamine added in an incubator set to 5% CO2 and 37oC.  
Lentiviruses: A gene block with the sequence for MscL G22S fused to EGFP 
via a consensus cleavage sequence for TEV protease (IDT) was ordered and the DNA 
was inserted into the EcoRI and BamHI sites of the pLVX TetOne puromycin 
lentiviral vector (Takara). A gene block with optimized human codons for TEV 
protease (IDT) was ordered and this DNA was cloned into XbaI sites of lentiviral 
vector FUeqFP650. We generated lentiviruses in 293T cells as described.  
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In vivo Mouse Metastasis Experiments: MDA-MB-231 cells with doxycycline 
inducible expression of MscL G22S and constitutive click beetle green luciferase 
expression (231-MscL-CBG) and MDA-MB-231 cells with constitutive click beetle 
green luciferase-only (231-CBG) were injected bilaterally into 4th inguinal mammary 
fat pads of 6-10-week-old female NSG mice (Jackson Laboratory) on day 0. Three 
cohorts of mice were then studied: (1) 231-MscL-CBG mice treated with 1% sucrose 
in drinking water (n = 4); (2) 231-CBG mice with water containing 2 mg/ml 
doxycycline and 1% sucrose (n = 5); and (3) experimental group mice with 231-MscL-
CBG cells and with water containing both doxycycline and sucrose as for group 2 (n 
= 5). Primary tumor size was tracked at the site of injection for each mouse via 
bioluminescence imaging (IVIS Spectrum, Perkin-Elmer). At day 43 the mice were 
euthanized and bioluminescence images of the liver, lung, spleen organs were taken 
to quantify metastases. Statistical significance testing of primary tumor growth data 
consisted of two-tailed student t-tests amongst all groups for each day. Statistical 
significance testing of the photon flux, metastasis data consisted of taking the log 
transform of all data points and performing a two-tailed t-test. 
Stable Expression of MscL in MDA-MB-231 Cells: DNA constructs for the E. 
coli MscL WT were kindly provided by Boris Martinac (Victor Chang Cardiac 
Research Institute, Darlinghurst, Australia). The MscL WT construct was mutated 
to produce MscL G22S using a Q5® Site Direct Mutagenesis Kit (New England 
Biolabs, Ipswich, MA) and then subcloned into a lentiviral vector pLVX Puro (Takara 
Bio USA, Inc, Mountain View, CA). Lentivirus from constructs encoding only EGFP 
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(negative control, no MscL or EGFP-only) and EGFP-P2A-MscL G22S with FLAG tag 
inserted just after MscL residue I68 [100] were harvested from human embryonic 
kidney 293 T (HEK293T) cells. Metastatic breast cancer cells, MDA-MB-231, were 
transduced with either virus and maintained in RPMI 1640 supplemented with 10% 
fetal bovine serum, 10,000 units/mL of penicillin, 10,000 µg/mL of streptomycin, and 
25 µg/mL of amphotericin B. For immunofluorescence imaging and flow cytometry 
analysis, MDA cells were fixed and permeabilized using methanol or fixed using 2% 
paraformaldehyde (PFA) for surface labeling with anti-FLAG iFluor 647 antibodies 
(Genscript, Piscataway, NJ). Analysis of infrared Western blots was conducted using 
a LI-COR Odyssey Sa system (Lincoln, Nebraska USA) and flow cytometry analysis 
was performed on a Millipore Sigma Guava® easyCyte flow cytometer (Burlington, 
MA). 
MscL Osmotic-shock Functional Assay: MDA-MB-231 cells were suspended in 
solutions of varying osmolality containing 100 µM propidium iodide (PI) (Sigma-
Aldrich, St. Louis, MO). PI is impermeable to the plasma membrane and label nucleic 
acids upon entering the cells. Prior to incubation, all cells were detached from culture 
dishes using 5 mM EDTA and counted using a Millipore ScepterTM to assure each 
bulk sample contained an equal number of cells of ~105. Sample fluorescence 
intensity due to PI uptake by the cells was measured using a Biotek Synergy H1 plate 
reader (Winooski, VT). Background fluorescence intensity was subtracted from data 
and values were normalized to the number of cells per bulk sample. Fluorescence 
 56 
imaging of the samples was also performed on a Biotek Cytation 5 imaging plate 
reader and image processing was done using ImageJ (http://rsb.info.nih.gov/ij/). 
In vitro Microfluidic Migration Device: The microfluidic device including 2D 
migration channels (cross-section: 50 µm x 10 µm and 20 µm x 10 µm) and narrow 3D 
constriction channels (cross-section: 10 µm x 10 µm, 6 µm x 10 µm, and 3 µm x 10 µm) 
was designed to be similar to previous migration devices [61, 99]. The device was 
designed to allow the chemoattractant gradient of fetal bovine serum (FBS) to be 
quickly established (~1hr) across all channels and that the gradient remained 
uniform and steady over the course of ~12 hrs, as verified through COMSOL 
Multiphysics (Burlington, MA) simulations. Soft lithography was used to fabricate 
the device out of polydimethylsiloxane (PDMS) (Dow Chemical, Midland, MI). The 
device design patterns were drawn in AutoCAD (San Rafael, CA) and printed onto a 
lithographic mask by CAD/Art Services (Bandon, OR, USA). The mask pattern was 
transferred onto SU-8 on a silicon wafer to produce the device mold for forming the 
PDMS cast. After punching inlets and outlets, the PDMS cast was then irreversibly 
bonded to a glass slide or coverslip following oxygen plasma treatment. 
In vitro Migration Experiments: Assembled microfluidic migration devices 
were treated with 50 µg/mL of fibronectin (Sigma Aldrich, St. Louis, MO) in 1X PBS. 
The devices were then incubated for 1 hr at room temperature. After incubation, the 
devices were rinsed with 1X PBS and filled with phenol red-free RPMI 1640 media 
supplemented with 2% FBS and stored at 37o C. MDA cells were then detached from 
cell culture dishes using 5 mM EDTA and resuspended in phenol red-free RPMI 1640 
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media supplemented with 2% FBS and slowly pipetted into the cell inlet of the 
microfluidic migration device. Gravity driven flow, as a result of differential 
hydrostatic pressure in the device inlets and outlets, pushed the cells near the 
opening of the channels. Once a sufficient number of cells were at the entrance of the 
device channels, the gravity flow was removed by equalizing the height of the media 
in all inlets and outlets. The cells were incubated in the device for 30 minutes at 37o 
C and 5% CO2 to allow them to adhere to the device bottom surface. Media was then 
gently removed from the chemoattractant inlet and replaced with media 
supplemented with 20% FBS. Migration devices were then mounted onto an Olympus 
spinning disk confocal microscope (Center Valley, PA). Time-lapse, ∆t = 12 minutes, 
DIC and fluorescence images of cells in the devices were taken for 8-12 hrs on an 
Andor EMCCD camera using image acquisition software Metamorph. 
Migration Tracking and Data Analysis: Time-lapse movies of cell migration in 
devices were first saved and organized using ImageJ software. For each movie, frame 
drift correction and manual cell position tracking were performed using MATLAB 
CellTracker [101]. All cells were binned into groups based on the width of the channel 
the cell travelled across. Cells were only tracked when fully inside of the channel and 
were tracked exclusively at the leading end. Average velocity for each cell was then 
calculated and the velocity distribution for each channel width was displayed using 
boxplots. Statistical significance testing of migration data consisted of two-tailed 




Expression of Non-native Channel, MscL G22S, Impairs Metastasis to Mouse 
Lung: We first set out to test our hypothesis that expression of MscL G22S in 
metastatic cancer cells results in disruption of cell migration mechanisms and thus 
reduces metastasis by using an in vivo mouse model and doxycycline inducible 
expression system for MscL G22S in MDA-MB-231 cells [61, 99] (Figure 4.1). Here 
MDA-MB-231 cells express click beetle green (Cbg) luciferase for bioluminescence 
imaging of the cells and tumors within the mice. Some cells contain a doxycycline 
inducible expression vector for MscL G22S–TEV cleavable linker (TC)–EGFP. When 
TEV protease is constitutively expressed, it unlinks MscL G22S from EGFP to 
minimize EGFP’s effect on MscL mechanosensitivity and function. Pre-TEV 
proteolysis MscL G22S is shown localizing to various cellular membranes and post-
TEV proteolysis, EGFP is unlined and diffuse within the cell (Figure 4.1B, C). This 
was used to first determine MscL’s localization in the MDA cells and then for our in 
vivo mouse experiments respectively. 
Three cohorts of immunodeficient mice (1) injected with MDA-MB-231 MscL 
G22S luciferase cells given sucrose feed (2) injected with MDA-MB-231 luciferase only 
cells with doxycycline given sucrose feed, and experimental group (3) injected with 
MDA-MB-231 MscL G22S luciferase cells given doxycycline and sucrose feed (Figure 
4.2A). Cohorts 1 and 2 were used to assess the effect of the non-induced MscL G22S 
construct and of doxycycline on the experimental results respectively. Luminescence 
imaging, used to track the primary tumor size change at the initial site of injection 
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over a period of ~5 weeks, showed no marked difference among the mouse cohorts 
suggesting that expression of MscL G22S had no significant effect on the development 
of the orthotopic tumor (Figure 4.2B). At the conclusion of the experiment the mice 
were euthanized and luminesce imaging was done of multiple organs to detect and 
quantify metastases (Figure 4.2C). The most notable finding is the reduced 
metastasis in the lung for cohort 3 relative to cohorts 1 and 2 (Figure 4.2D). This piece 
of evidence indicates that MscL G22S expression in metastatic breast cancer cells can 
impair metastasis. However, if the effect is due to specific disruption of cell migration 
in narrow 3D confinements cannot be discerned. For this, we study the cell migration 
using an in vitro microfluidic system that can mimic the narrow cross-sections we 
suspect are leading to MscL’s ability to disrupt migration and metastasis. 
Stable and Functional Expression of Bacterial MscL in MDA-MB-231: To 
eliminate the need for doxycycline induction, luciferase expression, and to have 
constitutive MscL expression, stable MDA-MB-231 EGFP (also referred to as no 
MscL) and EGFP-P2A-MscL G22S with FLAG-tag cell lines were generated using a 
lentiviral expression scheme (Figure 4.3A). Bicistronic expression of cytosolic EGFP 
and bacterial MscL G22S was achieved using a single DNA promoter and a P2A 
linker. When translated, a peptide bond at the end of the P2A linker fails to be made 
and thus the EGFP and MscL G22S proteins were expressed in immediate succession, 
but not as a single protein. Whole-cell western blot analysis using anti-FLAG showed 
robust expression of bacterial MscL G22S in the mammalian metastatic breast cancer 
cells (Figure 4.3B). In previous studies of MscL expressed in mammalian cells, MscL 
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localized to the cell plasma membrane as well as multiple membrane bound entities 
within the cell [57, 62]. Flow cytometry fluorescence intensity distributions for MDA 
MscL G22S with periplasmic FLAG-tag for fixed/permeabilized cells and fixed cells 
for surface labeling were both shifted towards the right compared to MDA no MscL 
cells indicating both intracellular and plasma membrane localization of MscL  (Figure 
4.3C). Direct comparison between the MDA MscL G22S permeabilized and surface 
labeling distributions showed that permeabilized cells had higher fluorescence inten-
 
Figure 4.1 Doxycycline Inducible MscL-TC-EGFP Lentiviral Scheme for MDA MB 231. (A) Cells were co-
transduced with a doxy inducible lentiviral vector encoding for MscL G22S-TEV Cleavable linker-EGFP and 
constitutive TEV protease vector. When TEV protease is co-expressed TC linker is hydrolyzed and MscL and 
EGFP are disconnected. (B) Fluorescence confocal images of MDA MB 231 MscL G22S EGFP cells without and 
with TEV expression (left panels: 1-imaging plane, right panels: z-stack superposition). (C) Graphs are 
fluorescence intensity profiles of DAPI and EGFP across line ab shown in the images. Without TEV, EGFP is 
bound to MscL G22S and has maximum fluorescence intensity/localization at the membranes (e.g., plasma 
membrane, ER, and nuclear membrane).  With TEV expressed, EGFP is unbound, diffuse and cytosolic, not 
localizing to any specific area. Scale bar = 25 µm. 
Stable cell-line generation with lentivirus 
MDA-MB-231 
MscL G22S TC 
EGFP 
MDA-MB-231 
MscL G22S TC 






Figure 4.2 In vivo Experiment for Determining MscL’s Effect on Cancer Cell Metastasis. (A) Cartoon description 
of in vivo experiments. MDA-MB-231 cells with doxycycline inducible expression of MscL G22S and constitutive 
luciferase expression and MDA cells with constitutive luciferase-only were injected under the mammary fat pad 
of immunodeficient mice on day 0. Three cohorts of mice were then studied, negative control groups (1) mice with 
MDA-MB-231 MscL G22S luciferase cells with sucrose feed (n = 4), (2) mice with MDA-MB-231 luciferase only 
cells with doxycycline and sucrose feed (n = 5), and experimental group (3) mice with MDA-MB-231 MscL G22S 
luciferase cells with doxycycline and sucrose feed (n = 5). (B) Average primary tumor size fold change at the site 
of initial injections as determined using bioluminescence imaging of mice on different days. Error bars are 
standard error of the mean. (C) Images of extracted liver and lung with luminesce signal false coloring and 
corresponding photon flux scale from a mouse of each cohort on day 43 relating to metastatic cancer cells at these 
secondary sites. Scale bar = 1 cm. Logarithmic plot of average luminescence signal, the result of metastatic cancer 
cells, described as photon flux for various organs of each cohort. Error bars represent the relative error of the 
mean. Vertical axis starts above luminescence background signal at 5x106 p/sec/cm2/sr. Two-tailed student t-test 
of log transformed data, *p ≤ 0.05. 
 
-sity and thus more labeling with anti-FLAG. Immunostaining of adherent 
permeabilized and surface labeled MDA MscL G22S cells reiterated these findings, 
showing that permeabilized cells had higher and more consistent labeling relative to 




Figure 4.3 Viral Expression System for Constitutive Expression of MscL G22S in MDA-MB-231 Cells. (A) A single 
lentivirus vector system for bicistronic expression of cytosolic EGFP and MscL with single promoter. Downstream 
of the promoter, EGFP and MscL genes are encoded with a P2A linker sequence in between. The DNA for EGFP-
P2A-MscL is transcribed into a single mRNA. Translation into protein results in an incomplete peptide bond of 
the P2A linker’s final amino acid resulting in the expression of separate EGFP and MscL proteins. (B) Western 
blot analysis of transduced whole cells with negative control vector, no MscL EGFP-only, and experimental cells, 
EGFP-P2A-MscL G22S with periplasmic FLAG-tag. GAPDH was used as a housekeeping protein. (C) Flow 
cytometry fluorescence analysis using anti-FLAG Alexa Fluor® 647 of methanol fixed and permeabilized cells 
(left), and PFA fixed cells for surface analysis (right). Negative controls were EGFP-P2A-MscL G22S cells with no 
anti-FLAG and no MscL EGFP-only cells with anti-FLAG, and experimental cells were EGFP-P2A-MscL G22S 
with anti-FLAG. (D) Immunostaining of FLAG for no MscL EGFP-only cells (top) and EGFP-P2A-MscL G22S 
with FLAG-tag (bottom) with methanol permeabilization and fixation (2-left most panels) and PFA fixed cells for 
surface analysis (2-right most panels). DAPI was used to label cell nuclei. Scale bar = 25 µm. 
 
An osmotic down-shock functional assay using impermeable dye, propidium 
iodide (PI), was performed on the MDA cells to determine if MscL mechanosensitive 
function was preserved and expression on the plasma membrane was sufficient for 
easily discernable mechanical activation as we have shown previously [62]. This 











function as an emergency release valve that prevents cell lysis under osmotic down-
shock by sensing increased membrane tension and allowing the flux of osmolytes 
across the bacterial cell inner membrane [102]. Simply, MscL in the mammalian cells 
was gated by osmotic down-shock (i.e., suspending the cells in solutions with 
osmolality much less than that inside of the cell) and fluorescence intensity from 
impermeable dye uptake was used to report MscL activation. The large size of MscL’s 
open pore, ~30 Å, allows free passage of osmolytes ≤ 10 kDa [31, 57]. Propidium iodide, 
an impermeable molecule of 668.4 Da that intercalates in nucleotides, when unbound 
and in solution has excitation and emission peaks of 493nm and 636 nm respectively. 
Once PI is bound, its fluorescence intensity can increase 20- to 30-fold and excitation 
and emission peaks are shifted to 535 nm and 617 nm respectively. Confocal imaging 
of the MDA cells showed an increase in cell midplane cross-sectional area with 
decreasing osmolality: 1.92x fold for the 75 mmol/kg condition and 3.15x fold for 35 
mmol/kg condition compared to the more iso-osmotic condition, 235 mmol/kg (Figure 
4.4A, B) for MDA MscL G22S cells. MDA no MscL cells showed an increase in cell 
area with decreasing osmolality as well of 2.03x fold for the 75 mmol/kg condition and 
2.87x fold for 35 mmol/kg condition compared to the more iso-osmotic condition, 235 
mmol/kg (Figure 4.4C). The increase in cell cross-sectional area was caused by 
osmosis across the plasma membrane and into the cell. This swelling resulted in 
membrane tension sufficient for MscL gating and PI uptake. PI fluorescence intensity 
increased as the solution osmolality decreased (Figure 4.4D). The level of expression 
of MscL within the MDA cells allowed for significant differences in the measurable 
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PI uptake in MscL G22S expressing cells versus no MscL cells for the more extreme 
osmotic down-shock conditions 75 mmol/kg and 35 mmol/kg. All together, these 
results support that MscL G22S can be expressed and mechanically gated in 
metastatic breast cancer cells, MDA-MB-231. 
 
Figure 4.4 Osmotic Down-shock Functional Assay for MscL in MDA Cells. Phase and fluorescence confocal images 
of cells under suspended in solutions of varying osmolality (e.g., 235 mmol/kg ~ isotonic condition, 35 mmol/kg ~ 
hypotonic condition) with 100 µM of impermeable PI after 3 minutes of (A) MDA MscL G22S cells and (B) MDA 
no MscL cells. (C) Comparison of different cell type average area of cell midplane cross-section for different osmotic 
conditions. Inset is the comparison of same cell type average area for different osmotic conditions. (D) Average 
fluorescence intensity of PI uptake for cells in suspension under varying osmolality (ncells ≈ 105, nexp = 10) for 6 




In vitro Microfluidic Migration Device with Narrow 3D Confinements: A 
microfluidic device was used to study the migration of the MDA cells in narrow 
confinements more robustly and precisely (Figure 4.5A). The device was designed to 
contain migration channels of varying cross-section for 2D, planar (channel widths: 
20 and 50 µm) and narrow 3D confinement migration (channel widths: 3, 6, and 10 
µm). Gravity driven flow was used to add cells to the device, situating them near the 
channel entrances, and to introduce a chemoattractant gradient that promoted cell 
chemotaxis across the channels. An FBS gradient was established quickly across all 
channels within 2 hrs and remained stable for >10 hours (Figure 4.5B). Confocal 
imaging showed that cells entered the different sized channels. Cells in the larger, 
2D channels were not in contact will all of the channel walls, however cells in the 
narrower confinements appeared to completely “plug” the channels (Figure 4.5C). 
Cancer cell migration under this type of confinement has been shown to elicit and is 
required for the osmotic engine migration mechanism [61, 99]. Isometric volume views 
demonstrate the extent of cell deformation and conformation to the channel shape 
(Figure 4.5D).  
Only Cancer Cells with Activated MscL G22S had Disrupted Migration in 
Narrow 3D Confinements: Our in vivo mouse experiments showed that introduction 
of MscL G22S into metastatic cancer cells led to impairment of metastasis to the 
lungs. By using the in vitro microfluidic migration device, we were able to ascertain 
if this outcome was a result of cell migration in narrow confinements. Phase and 
fluorescence time-lapse imaging of the cancer cells were used to determine the influe- 
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Figure 4.5 Microfluidic Platform for Study of Cancer Cell Migration Across 2D Channels and Narrow 3D 
Constrictions. (A) Cartoon of the PDMS microfluidic migration device. Cells are added to the device via a cell inlet 
and flow into the bottom section of the device, then they adhere to the glass substrate and migrate across channels 
of various sizes as a response to an FBS chemoattractant gradient as shown in the zoomed-in views. (B) Time-
lapse images of multi-physics simulation of FBS gradient in the microfluidic device. (C) Fluorescence images 
showing orthogonal views, y-x and z-x, of cells in the microfluidic device channels. The z-x cross-sections of the 
labeled, turquoise lines on the y-x view are shown for cells in all channel widths. The PDMS/device walls appear 
black in the images, and the channels are filled with media containing BSA-rhomadime. Cells express cytosolic 
EGFP. Scale bar = 20 µm. (D) Isometric view of the cells in the narrow 3D constriction channels. 
 
-nce of channel size and MscL G22S expression on cell migration. Cells migrated 
across the device in the direction of the chemoattractant gradient for ~10-12hrs and 
their change in position was manually tracked (Figure 4.6). Using PI during cell 
migration tracking showed a low proportion, 0-6%, of MscL G22S cells taking up dye 
when entering channels of 6, 10, 20, and 50 µm width (Figure 4.7A). In contrast, a 
larger proportion, 46.2%, of MscL G22S cells showed PI uptake when entering the 

































































































G22S activation in cells when migrating in the device. We found that the average cell 
velocity for the population of cells in the different sized channels decreased with 
narrower channel width for both no MscL and MscL G22S cells (Figure 4.7B-C). For 
MDA no MscL cells, the cell velocity from cell to cell varied more greatly for cells in 
the 10, 20, and 50 μm width channels, following a broader normal distribution of 
single cell velocity measurements. MDA no MscL cells in the 3 and 6 μm width 
channels had narrower velocity distributions (Figure 4.7B).  
The velocity measurement distributions for MDA MscL G22S cells were 
consistently narrower (Figure 4.7C). Comparison of velocity of the no MscL and MscL 
G22S cells for 3D confined channel widths showed no statistically significant 
difference between the two cell types (Figure 4.7D). These results do not clearly 
indicate that MscL expression and potentially activation impair cancer cell migration 
in 3D narrow confinements. Revisiting our findings on MscL activation in the 
channels provided elucidation on this initially perceived discrepancy in our in vivo 
and in vitro results (Figure 4.7A).  
Treating MscL G22S activated cells and MscL G22S non-activated cells that 
entered the 3 μm width channels as two separate populations showed that 87.5% (7 
out of 8) of cells that successfully entered the channels and migrated (i.e., within a 
time frame of ~6hrs) did not have MscL activation. This in turn meant that only 
12.5% of the 3 μm migrating MscL G22S cells were able to migrate. Our average 
velocity comparison between the no MscL and MscL G22S cells can then be inferred 
to have been appreciably influenced by the non-activated MscL G22S cells, resulting 
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Figure 4.7 Analysis of Cancer Cell Migration In vitro. (A) Proportion of cells exhibiting PI uptake while entering 
or migrating across channels for different channel width. (B) Average velocity of MDA no MscL cells in the 
different sized channels of the microfluidic device. Circles represent average migration of individual cells; black 
bars are the average velocity for all cells for the given channel width and curves show a normal distribution for 
each group of cells. (C) Average velocity of MDA MscL G22S cells in the different sized channels of the microfluidic 
device. Circles represent average migration of individual cells; black bars are the average velocity for all cells for 
the given channel width and curves show a normal distribution for each group of cells. (D) Box plots of average 
cell migration for no MscL and MscL G22S cells in the different sized channels. Two-tailed student t-test, **p ≤ 
0.01. 
 
in similar average velocity, even in the narrow confinements. When restricting our 
analysis to MscL G22S activated cells, we found that ~89% (8 out of 9) of these cells 
were stuck at the 3 μm channel entrance, not migrating in the channels (Figure 4.8). 
These findings are more in alignment to what was observed from our in vivo model. 
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Figure 4.8 Cartoon Depicting Migratory and Stuck MDA MscL G22S Cells that Entered 3 μm Width Channels. 
Stuck cells represent cells that partially entered channels but were unable to fully enter the channels, remaining 
at the channel entrances for ~6 hrs.  
 
Discussion 
We were able to show that the expression of exogenous MscL G22S in 
metastatic breast cancer cells impaired metastasis to the lung of mice. However, 
when studying the cell migration in vitro the results suggest that migration of the 
MscL G22S cells and no MscL cells via narrow, 3D confinements are not different. 
However, MscL activation was observed for ~46% of cells the MscL G22S cells that 
were stuck or migrated across the 3 µm width channel. Of the total migratory cells, 
87.5% were non-activated cells. Of the activated cells, ~89% were stuck and not 
migratory. This shows that if MscL G22S is activated, it can indeed impair cancer 
cell migration in 3D confinements. However, ~54% of MscL G22S cells did not exhibit 
MscL G22S cells that enter 3 µm channels 
(t ≤ 6hrs) 
migratory stuck 
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MscL G22S activation. This may be indicative of some unknown physiological factors 
not captured in our in vitro experiments such as osmotic variability, more complex 
topography or microenvironment more closely resembling the lung [103-105]. 
Incorporating this into our in vitro platform may result in higher cell proportions with 
MscL G22S activation and thus more cells becoming stuck. 
Nevertheless, functional expression of an exogenous, mechanically gated 
channel such as MscL G22S resulted in reduced metastasis to the lung. Breast cancer 
has preferential metastasis to bone, lung, liver, and brain. The reasons for this have 
been linked to genetic influence leading to breast cancer subtypes that show 
metastatic variability but there is also physical factors that are becoming more 
apparent through research [88, 89, 106, 107]. Each of the organs have very distinct and 
different tissue architecture, mechanical properties, and composition yet breast 
cancer cells are able to metastasize to each one [108]. However, metastasis can be very 
different. For our own in vivo experiments, we were only able to perform necropsy on 
lung and liver, but already these two organs showed different results when compared 
to respective controls.  
Given our findings, key next steps that can be taken to more precisely 
determine the cause of our finding for in vivo metastasis to lung would be redesigning 
a microfluidic platform with channels that have variable channel widths to better 
recapitulate the paths and pores encountered by the cells in vivo, incorporating a lung 
epithelium co-culture or means to trigger a phenotypic transition in the MDA cells[89, 
108-110], or also varying solution osmolality while maintaining uniform 
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chemoattractant concentration. Investigating in vivo metastasis to other organs may 
be interesting as well to determine if the effect of MscL on cancer cell metastasis is 
lung specific or are the same results potentially observable in bone and brain. 
 
Conclusions and Implications 
We were able to demonstrate that MscL can be functionally expressed in 
metastatic cancer cells. MscL G22S expression in MDA-MB-231 cells was able to 
impair metastasis to lung in mice, in vivo. When investigating the role of 3D 
confinement on these results using an in vitro microfluidic device, our initial findings 
showed no marked difference in the average velocity of the no MscL and MscL G22S. 
However, more in-depth analysis showed that of the MscL G22S cells migrating in 
the narrowest confinement, 87.5% had non-activated MscL and of the active MscL 
G22S cells, ~89% became stuck. Taken together this shows that confined migration 
can result in MscL activation and this leads to impaired migration. However, MscL 
activation in vivo may not be solely due to 3D confined migration, needed further 
study. 
Through our work we showed that MscL can be used to better understand or 
impair metastasis in vivo. And in our first studies, determine that straight channel, 
3D confinement is not sufficient to recapitulate what occurs in vivo; and other factors 








Conclusion & Future Work 
In this thesis, it was shown that expression of bacterial MscL in mammalian 
cells endowed the cells with novel mechanotransduction capabilities, where we 
demarcate mechanotransduction as mechano-sensing of external mechanical forces, 
intercellular biochemical signaling, and altered cell function/behavior response. In 
particular, MscL conferred new mechano-sensing of membrane tension as a result of 
osmotic shock or integrin-actin linked ATC that led to channel activation and flux of 
molecules across the plasma membrane and altered cell function, the impairment of 
breast cancer metastasis to mice lung in vivo and migration in narrow 3D confined 
channels of 30 μm2 cross-section in vitro. 
These effects resulting from functional MscL expression were not exclusive to 
a single mammalian cell-line, but rather a variety of mammalian cells such as human 
retinal epithelial cells, Chinese hamster ovary cells, and MDA-MB-231metastatic 
breast cancer cells. This highlights MscL’s applicability to many cell types that differ 
in phenotype such as epithelial versus mesenchymal, species origin, and healthy 
somatic cells versus cancer cells. For all of these cell lines MscL, was robustly 
expressed using standard adenoviral and lentiviral vectors and procedures. 
Optimization of the mscL gene was not necessary and constitutive expression did not 
negatively impact cell viability. High transduction efficiency and protein expression 
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were observed. This is perhaps attributed to MscL’s relatively short genetic sequence 
and amino acid sequence, ~411 bp per subunit. Within each cell, MscL was also able 
to localize to multiple lipid membranes showing its potential as an intercellular probe 
or tool. Previous work has indicated that MscL does rely on lipid membrane 
composition, in particular mechano-sensing occurs when the membrane contains 
phosphatidylethanolamine (PE) [111, 112]. Whether this can impact MscL localization 
and function in mammalian cells, as lipid compositions from cell type to cell type and 
organelle to organelle[113], has not been investigated.  
The osmotic down-shock functional assay was able to verify MscL mechano-
sensing for these mammalian cell lines. Modifications to the assay, for example using 
fluorescence imaging for 2D substrate adherent cells and bulk fluorescence intensity 
measurements from a cell suspension for non-adherent cells, were successfully 
performed.  
Ultimately here we have started to develop MscL’s mechanotransduction 
repertoire and prove its versatility as a mechanobiology tool. We have already shown 
that MscL can be used as a tool for delivery of large, impermeable molecules into live 
cells using various types of mechanical stimulus. Our metastasis and migration 
studies have shown how MscL can provide insight into the metastatic cascade and, 
potentially, mechanobiology focused therapies. We hope that this work inspires 
further research utilizing MscL in mammalian cells to study existing 
mechanotransduction or potentially engineer new mechanical properties and/or 
signaling in cells, expanding the field of mechanobiology as we know it. 
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Future work involving MscL that can further this area of research would 
include studying our missing component of mechanotransduction: the effect of MscL 
activation on signaling pathways in cells and vice versa. Mechanotransduction 
pathways of interest would be Rho, Rac, and Cdc42 which are linked to proliferation,, 
survival, migration, and actin remodeling[114, 115]. This would also go hand-in-hand 
with studying MscL’s influence on other cell functions. 
MscL can also be reimagined to answer more sophisticated and difficult 
questions or accomplish better engineered mechanotransduction. For example, as 
mentioned previously, MscL localized to multiple membranes in mammalian cells. By 
fusing different leader sequences to MscL, the channel can be selectively trafficked 
to specific membranes within the cell[116, 117]. This can lead to more fine-tuned, 
subcellular study or effect of MscL mechanotransduction.  
MscL can also be engineered to serve more literally as a tool for 
mechanobiology studies such as an in-situ membrane tension sensor. Plasma 
membrane tension is difficult to decouple from cortical tension and thus measure, 
often requiring use of optical tweezers[118]. Previous work focused on determining 
MscL open pore size and helix-tilt gating utilized Förster Resonance Energy Transfer 
(FRET)[31, 119, 120]. FRET signal from fluorophore tagged cysteine residues was used to 
correlate to MscL pore size. Given MscL’s known open probability as a function of 
membrane tension, FRET signal can then be correlated to membrane tension. 
Finally, it would be interesting to see if MscL mechano-sensing can be enhanced 
through direct linkage to native mechanosensors such as the actin cytoskeleton. As 
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shown in our work, mechanical perturbation of integrins linked to actin led to MscL 
activation at the plasma membrane. One could expect that direct connection to the 
actin cytoskeleton could amplify the mechanical input sensed by MscL.  
We have shown in this thesis, how bacterial MscL can be successfully 
expressed and mechanically gated in various mammalian cells, conferring these cells 
with novel, and desirable mechanotransduction. Therefore, we have demonstrated 
the potential for repurposing bacterial MscL for study in mammalian cells, both for 
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